Memento Vivereremember to live
Data fetched

Not medical advice. This page maps what exists: what is approved, what is being studied, and where. Whether a trial takes you is up to the trial team.

All diseases

Multiple sclerosis

Also called MS.

58approved drugsFDA label598trials recruiting427 open now35late stagePhase 3 and 458countrieswith a trial site2026-10newest papertrial or review

What it is

A progressive autoimmune disorder affecting the central nervous system resulting in demyelination. Patients develop physical and cognitive impairments that correspond with the affected nerve fibers.

Multiple sclerosis (MS) is a disease that affects your brain and spinal cord, also called the central nervous system. MS damages myelin, the protective coating around your nerve cells. Myelin helps nerves send messages quickly. When it's damaged, messages between your brain and body slow down or get blocked. This leads to MS symptoms.What are the types of multiple sclerosis? Not everyone with MS has the same experience. MS is grouped into types based on how the disease changes over time. Types of MS include:Relapsing-remitting MS. The most common type. Read more at MedlinePlus.

Source: Monarch Initiative, MONDO:0005301 and MedlinePlus, fetched 2026-11-10.

Causes

Gene associations arrive in a later milestone.

MedlinePlus has a plain-language page on causes and risk factors: Multiple Sclerosis.

Source: MedlinePlus, fetched 2026-11-10.

Approved treatments

58 drugs whose FDA (United States) label names this disease under indications. Approval elsewhere differs.

  • Alemtuzumab (Lemtrada)Genzyme CorporationLEMTRADA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease, in adults. Because of its safety profile, the use of LEMTRADA should generally be reserved for
  • Ammonia, Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine (Physician Ez Use Joint Tunnel And Trigger Kit)Asclemed USA, Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • BaclofenDirect_RxBaclofen tablets, USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen treatment will aid in
  • Betamethasone Acetate And Betamethasone Sodium Phosphate (Celestone Soluspan)Sportpharm LLCherapy. Neoplastic Diseases For palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory cond
  • Betamethasone Sodium Phosphate And Betamethasone Acetate (Betaloan Suik)Advanced Rx Pharmacy of Tennessee, LLCherapy. Neoplastic Diseases For palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory cond
  • Betamethasone Sodium Phosphate And Betamethasone Acetate, Bupivacaine Hydrochloride, Povidine Iodine (Marbeta 25 Kit)Asclemed USA, Inc.herapy. Neoplastic Diseases For palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory cond
  • Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine, Isopropyl Alcohol (Marbeta L Kit)Advanced Rx of Tennessee, LLCherapy. Neoplastic Diseases For palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory cond
  • Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Iodixanol, Povidine Iodine (Bl-C Kit)Asclemed USA, Inc.herapy. Neoplastic Diseases For palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory cond
  • Betamethasone Sodium Phosphate, Betamethasone Acetate, Lidocaine, Povidine Iodine (Betalido Kit)Asclemed USA, Inc.herapy. Neoplastic Diseases For palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory cond
  • Bupivacaine Hydrochloride, Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidine Iodine (Blt-25 Kit)Asclemed USA, Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • CladribineApotex Corp.Cladribine tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-remitting disease and active secondary progressive disease in adults. Because of its safety profile, use of cladribine tablets is generally recommended fo
  • DalfampridineGolden State Medical Supply, Inc.AND USAGE Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies (14) ]. Dalfampridine is a potassium channel blocker indicated to improve walking in adult patients
  • Dantrolene SodiumPar Health USA, LLCf clinical spasticity resulting from upper motor neuron disorders (e.g., spinal cord injury, stroke, cerebral palsy, or multiple sclerosis). It is of particular benefit to the patient whose functional rehabilitation has been retarded by the sequelae of spasticity. Such patients must have presumably reversible spasticit
  • DexamethasoneAdvanced Rx Pharmacy of Tennessee, LLC. Neoplastic Diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury. Ophthalmic Diseases: Sympathetic ophthalmia, temporal arteritis, uveitis, and ocular i
  • Dexamethasone 1.5 MgProficient Rx LP. Neoplastic Diseases: For the palliative management of leukemias and lymphomas. Nervous System: Acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury. Ophthalmic Diseases: Sympathetic ophthalmia, temporal arteritis, uveitis, and ocular i
  • Dexamethasone IntensolSportpharm LLCpy. Neoplastic Diseases For the palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury. Ophthalmic Diseases Sympathetic ophthalmia, temporal arteritis, uveitis, and ocular in
  • Dexamethasone Sodium PhosphateHikma Pharmaceuticals USA Inc.me, without uremia, of the idiopathic type or that due to lupus erythematosus 12. Nervous system Acute exacerbations of multiple sclerosis 13. Miscellaneous Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate anti-tuberculosis chemotherapy Trichinosis with neurologi
  • Dimethyl FumarateMSN LABORATORIES PRIVATE LIMITEDDimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Dimethyl fumarate is indicated for the treatment of
  • Dimethyl-Fumarate (Dimethyl Fumarate)Glenmark Pharmaceuticals Inc., USADimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Dimethyl fumarate delayed-release capsules are indic
  • Diroximel Fumarate (Vumerity)Biogen Inc.VUMERITY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. VUMERITY is indicated for the treatment of relapsing
  • FingolimodAvKAREFingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod capsules are
  • Fingolimod Hcl (Fingolimod)Rising Pharma Holdings, Inc.Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod is a sphingos
  • Fingolimod Hydrochloride (Fingolimod)Ascend Laboratories, LLCFingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod capsules are
  • Fingolimod Lauryl Sulfate (Tascenso Odt)Cycle Pharmaceuticals LtdTASCENSO ODT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. TASCENSO ODT is a sphing
  • Glatiramer AcetateZydus Pharmaceuticals USA Inc.Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer acetate injection is indicated for the tr
  • Glatiramer Acetate Injection (Glatiramer Acetate)UPSHER-SMITH LABORATORIES, LLCGlatiramer Acetate Injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer Acetate Injection is indicated for the tr
  • HydrocortisoneAsclemed USA, Inc.er a critical period of the disease in: Ulcerative colitis Regional enteritis 12. Nervous System Acute exacerbations of multiple sclerosis 13. Miscellaneous Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy Trichinosis with neurologic
  • HydroxocobalaminActavis Pharma, Inc.rosives, extensive neoplasia), and a number of conditions associated with a variable degree of gastric atrophy (such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy). Total gastrectomy always produces vitamin B 12 deficiency. Structural lesions leading to vitamin B 12 defic
  • Interferon Beta-1A (Rebif)EMD Serono, Inc.REBIF is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Rebif is an interferon beta indicated for the treatm
  • Interferon Beta-1B (Betaseron)Bayer HealthCare Pharmaceuticals Inc.BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. BETASERON is an interferon beta indicated for the tr
  • Kenalog (Pro-C-Dure 6 Kit)Asclemed USA, Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • Lidocaine Hydrochloride, Triamcinolone Acetonide, Povidone-Iodine (Physician Ez Use Joint Tunnel And Trigger Kit Ii)Asclemed USA, Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • Lidocaine, Kenalog, Povidone Iodine (Lidolog Kit)Asclemed USA, Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • Marcaine, Kenalog, Povidone Iodine (Bupivilog Kit)Advanced Rx of Tennessee, LLC. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • Marcaine, Lidocaine, Kenalog, Povidone Iodine (Mlk Kit F2)Asclemed USA, Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • MethylprednisoloneBryant Ranch Prepacker a critical period of the disease in: Ulcerative colitis Regional enteritis 12. Nervous System Acute exacerbations of multiple sclerosis 13. Miscellaneous Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy. Trichinosis with neurologic
  • Methylprednisolone Acetate (Depo-Medrol)Asclemed USA, Inc.y. Neoplastic Diseases : For palliative management of: leukemias and lymphomas. Nervous System : Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic Diseases : Sympathetic opthalmia, temporal arteritis, uveitis, ocular inflammatory condit
  • Methylprednisolone Sodium SuccinateHikma Pharmaceuticals USA Inc.py. Neoplastic diseases For the palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive
  • MitoxantroneHospira, Inc.ical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly abnormal between relapses). Mitoxantrone is not indicated in the treatment of patients with primary progressive multiple scl
  • Monomethyl Fumarate (Bafiertam)Banner Life Sciences LLCBAFIERTAM is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. BAFIERTAM is indicated for the treatment of relapsin
  • Natalizumab-Sztn (Tyruko)Sandoz IncTYRUKO is an integrin receptor antagonist indicated for treatment of: Multiple Sclerosis (MS) TYRUKO is indicated as monotherapy for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active
  • Ocrelizumab (Ocrevus)Genentech, Inc.OCREVUS is indicated for the treatment of: Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults Primary progressive MS, in adults Relapsing-remitting
  • Ofatumumab (Kesimpta)Novartis Pharmaceuticals CorporationKESIMPTA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. KESIMPTA is a CD20-directed cytolytic antibody indic
  • Onabotulinumtoxina (Botox)Allergan, Inc.inary incontinence due to detrusor overactivity associated with a neurologic condition [e.g., spinal cord injury (SCI), multiple sclerosis (MS)] in adults who have an inadequate response to or are intolerant of an anticholinergic medication ( 1.1 ) Treatment of neurogenic detrusor overactivity (NDO) in pediatric patien
  • Ozanimod Hydrochloride (Zeposia 7-Day Starter Pack)Celgene CorporationZEPOSIA is indicated for the treatment of: relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. moderately to severely active ulcerative colitis (UC
  • Ponesimod (Ponvory)Vanda Pharmaceuticals Inc.PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PONVORY is a sphingosine 1-phosphate receptor modula
  • PrednisoloneAurobindo Pharma Limiteda critical period of the disease in: Ulcerative colitis Regional enteritis 12 . Nervous system. Acute exacerbations of multiple sclerosis 13. Miscellaneous Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy Trichinosis with neurologic
  • Prednisolone Sodium PhosphateProficient Rx LPe treatment of acute leukemia and aggressive lymphomas in adults and children. 8. Nervous System Acute exacerbations of multiple sclerosis. 9. Ophthalmic Diseases Uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids; temporal arteritis; sympathetic ophthalmia. 10. Respiratory Diseases Symp
  • PrednisoneA-S Medication Solutionser a critical period of the disease in: Ulcerative colitis Regional enteritis 12. Nervous System Acute exacerbations of multiple sclerosis 13. Miscellaneous Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy Trichinosis with neurologic
  • Prednisone D/PDirect_Rxover a critical period of the disease in: ulcerative colitis, regional enteritis Nervous System Acute exacerbations of multiple sclerosis Miscellaneous Tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy, trichinosis with neurologic or
  • Siponimod (Mayzent)Novartis Pharmaceuticals CorporationMAYZENT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. MAYZENT is a sphingosine 1-phosphate (S1P) receptor
  • Solu-CortefHF Acquisition Co. LLC, DBA HealthFirstpy. Neoplastic diseases For the palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive
  • Solu-MedrolHF Acquisition Co. LLC, DBA HealthFirstpy. Neoplastic diseases For the palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive
  • Solu-Medrol(R) Methylprednisolone Sodium SuccinatHF Acquisition Co LLC, DBA HealthFirstpy. Neoplastic diseases For the palliative management of leukemias and lymphomas. Nervous System Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy. Ophthalmic diseases Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive
  • TeriflunomideMylan Pharmaceuticals Inc.Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Teriflunomide tablets are a pyrimidine synthesis inh
  • Triamcinolone AcetonideAlembic Pharmaceuticals Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory co
  • Triamcinolone Acetonide, Lidocaine Hydrochloride, Bupivacaine Hydrochloride, Povidine Iodine (Mlk F4 Kit)Asclemed USA, Inc.. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory con
  • Ublituximab (Briumvi)TG Therapeutics, Inc.BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. BRIUMVI is a CD20-directed cytolytic antibody indica

Source: openFDA drug labels, fetched 2026-11-10.

Latest research

The newest randomized trials, meta-analyses and systematic reviews with this disease in the title. 4166 in total.

  1. Challenging historical associations and reassuring women: an updated meta-analysis of multiple sclerosis relapse risk following assisted reproductive technologyMult Scler Relat Disord ·
  2. Lacosamide effects on pain management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trialMult Scler Relat Disord ·
  3. A Brief emotion-focused psychodynamic intervention for fatigue, pain, and health-related quality of life in women with relapsing-remitting multiple sclerosis: A randomized pilot trialMult Scler Relat Disord ·
  4. One target, two evidence streams: Rituximab versus ocrelizumab in relapsing multiple sclerosis: A design-stratified systematic review, meta-analysis, and concordance assessmentMult Scler Relat Disord ·
  5. Anti-CD20 monoclonal antibody therapies in relapsing multiple sclerosis: A systematic review and meta-analysis of randomised controlled trialsMult Scler Relat Disord ·
  6. Efficacy and safety of autologous hematopoietic stem cell transplantation (AHSCT) versus alemtuzumab in multiple sclerosis: Systematic review and individual patient data meta-analysisMult Scler Relat Disord ·
  7. Safety and efficacy of anti-CD20 monoclonal antibodies versus teriflunomide in relapsing multiple sclerosis: a systematic review and meta-analysisActa Neurol Belg ·
  8. Treatment fidelity and adherence in a pilot physical activity randomized controlled trial for people newly diagnosed with multiple sclerosisMult Scler Relat Disord ·
  9. Primary results from the targeted exercise for African-Americans with multiple sclerosis projectContemp Clin Trials ·
  10. Epidemiology of multiple sclerosis in iran: an updated systematic review and meta-analysisMult Scler Relat Disord ·
  11. The role of viral infections and other microbial factors in the pathogenesis of multiple sclerosis: a systematic reviewMult Scler Relat Disord ·
  12. Passive digital monitoring via mobile apps and wearables in multiple sclerosis: A systematic reviewRev Neurol (Paris) ·
  13. Effects of neurofeedback and biofeedback on cognitive, affective, and motor outcomes in adults with multiple sclerosis: a systematic reviewMult Scler Relat Disord ·
  14. Virtual reality interventions and their impact on physical function and quality of life in multiple sclerosis: A systematic review with meta-analysisMult Scler Relat Disord ·
  15. Nimodipine in animal models of demyelination relevant to multiple sclerosis: a systematic reviewBrain Res ·
  16. Exercise-induced modulation of kynurenine pathway metabolite patterns in multiple sclerosis: a targeted metabolomics analysis across four randomized controlled trialsBrain Behav Immun ·
  17. Evidence-Based Cognitive Rehabilitation for Persons With Multiple Sclerosis: An Updated Systematic Review 2016 to 2024Arch Phys Med Rehabil ·
  18. Impact of Task-Oriented Training on Health Outcomes in Multiple Sclerosis: A Systematic Review and Meta-AnalysisAm J Phys Med Rehabil ·
  19. Effects of physical exercise on spasticity in people with multiple sclerosis: A systematic reviewPhysiotherapy ·
  20. Obsessive-compulsive disorder in people with multiple sclerosis: a systematic review and meta-analysisActa Neurol Belg ·

Source: Europe PMC, fetched 2026-11-10.

Trials recruiting now

598 studies on ClinicalTrials.gov are recruiting (427) or about to (171). Most advanced first. Phase 3 is the last step before approval; Phase 1 is the first time in people.

Phase 4 12 Phase 3 23 Phase 2/3 4 Phase 2 44 Phase 1/2 23 Phase 1 42 Early phase 1 16 No phase given 234 Observational 200

Loading all 598 trials for filtering…

Phase 4, after approval 12
  1. A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 TherapyNCT07609719 · Recruiting · started · OCR SCUnited States (7), Puerto Rico
  2. Silodosin for Urinary Symptoms in Female Patients With Multiple SclerosisNCT07614321 · Recruiting · started · Silodosin 8 mg; PlaceboUnited States
  3. Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple SclerosisNCT07389590 · Recruiting · started · Ublituximab; OcrelizumabUnited States
  4. Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower ExtremitiesNCT07303582 · Recruiting · started · Cryoneurolysis; Botulinum toxinUnited Kingdom
  5. Ublituximab (Briumvi) for Early Forms of Relapsing Multiple SclerosisNCT07225361 · Recruiting · started · UblituximabUnited States
  6. Glucose Consumption in MS Using [F-18]FDG-PETNCT07087106 · Recruiting · started · [F-18]FDGUnited States
  7. ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMSNCT06733922 · Recruiting · started · ETNATM-ProgMSCanada (14)
  8. Prospective Evaluation of Sequencing From antiCD-20 Therapies to OzanimodNCT06529406 · Recruiting · started · OzanimodUnited States (3)
  9. Home Based Infusions for OcrelizumabNCT04650321 · Recruiting · started · Ocrelizumab at homeUnited States
  10. Emerging Indications for Hyperbaric Oxygen TreatmentNCT07240649 · Not yet recruiting · started · Hyperbaric oxygen treatment (HBOT); 100% OxygenNo sites listed yet
  11. Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled TrialNCT07818356 · Not yet recruiting · started · Two-dose M0-M2 vaccination schedule; Two-dose M0-M6 vaccination scheduleFrance (24)
  12. A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)NCT07138833 · Not yet recruiting · started · Dimethyl Fumarate Enteric-coated CapsulesNo sites listed yet
Phase 3 23
  1. A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple SclerosisNCT07189325 · Recruiting · started · Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons); Anti-CD20 therapies (Ocrelizumab, Rituximab, Ofatumumab)France
  2. Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation ResearchNCT07623668 · Recruiting · started · Privosegtor; Methylprednisolone; PlaceboUnited States (4)
  3. A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisNCT07067463 · Recruiting · started · Orelabrutinib; PlaceboUnited States (19), Poland (18), Bulgaria (7), Spain (6) and 13 more
  4. A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNCT07299019 · Recruiting · started · Orelabrutinib; PlaceboUnited States (27), Poland (19), Georgia (6), Spain (6) and 16 more
  5. Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisNCT07325292 · Recruiting · started · Frexalimab; Frexalimab; MRI contrast-enhancing preparationsUnited States (34), China (7), Italy (7), Japan (7) and 3 more
  6. A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisNCT07225504 · Recruiting · started · Remibrutinib (blinded); Placebo; Remibrutinib (Open label)United States (43), Spain (22), France (21), China (20) and 32 more
  7. A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple SclerosisNCT07321093 · Recruiting · started · BCD-281; OcrelizumabRussia
  8. Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.NCT06846281 · Recruiting · started · Remibrutinib oral treatment; OcrelizumabUnited States (45), France (11), Spain (11), Germany (10) and 15 more
  9. Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisNCT06408259 · Recruiting · started · Ozanimod; Fingolimod; PlaceboUnited States (12), Spain (5), Italy (4), Portugal (4) and 7 more
  10. An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide Continued Ocrelizumab TreatmentNCT06675955 · Recruiting · started · OcrelizumabFrance (16), Russia (16), Ukraine (13), Germany (4) and 2 more
  11. Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple SclerosisNCT06136728 · Recruiting · started · Dalfampridine 10 MG [Ampyra]; Physical therapy; Dalfampridine plus physical therapyUnited States
  12. Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)NCT07403266 · Recruiting · started · YCJ-01 Full Spectrum cannbis Extract; PlaceboSpain
  13. A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple SclerosisNCT05906992 · Recruiting · started · CT-P53; US-Ocrevus; EU-OcrevusPoland
  14. Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabNCT05877963 · Recruiting · started · Ublituximab; PlaceboUnited States (41), Poland (10)
  15. RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.NCT05758831 · Recruiting · started · Perfusion of treatment Rituximab; Perfusion of treatment OcrelizumabFrance (23)
  16. Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MSNCT05834855 · Recruiting · started · RituximabNetherlands
  17. Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis ComplexNCT05534672 · Recruiting · started · Rapamycin; PlaceboPoland (2)
  18. Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)NCT04047628 · Recruiting · started · Autologous Hematopoietic Stem Cell Transplantation; Best Available Therapy (BAT)United States (23)
  19. A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple SclerosisNCT05179577 · Not yet recruiting · started · Arbaclofen; PlaceboNo sites listed yet
  20. A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)NCT07483632 · Not yet recruiting · started · Diroximel Fumarate; Dimethyl Fumarate; Fingolimod; Placebo matching DRFNo sites listed yet
  21. Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot ProjectNCT07472413 · Not yet recruiting · started · Cetirizine; DiphenhydramineUnited States
  22. Online Mindfulness-Based Cognitive Therapy for People With Multiple Sclerosis With Mild-Moderate DepressionNCT07742579 · Not yet recruiting · started · Mindfulness-Based Cognitive TherapyNo sites listed yet
  23. Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)NCT06663189 · Not yet recruiting · started · treatment withdrawal; Usual DMT continuation; MRI; Quality of Life questionnairesFrance (22)
Phase 2/3 4
  1. Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple SclerosisNCT07220252 · Recruiting · started · Ublituximab; Placebo; Placebo; FingolimodPoland (4), United States, Slovakia
  2. Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).NCT05961644 · Recruiting · started · Cladribine Subcutaneous Injection; 0.9% Chloride Injection SodiumPoland
  3. Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in InfantsNCT04987463 · Recruiting · started · Vigabatrin; Rapamycin; Placebo; PlaceboPoland (2)
  4. Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised TrialNCT04302870 · Recruiting · started · Memantine Hydrochloride Oral Solution; Trazodone Hydrochloride oral solution; Placebo oral solution; Amantadine Hydrochloride Oral SolutionUnited Kingdom (22)
Phase 2 44
  1. A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)NCT07840326 · Recruiting · started · SUN-627; PlaceboUnited States (7)
  2. The HIt HArd and hiT Early in Multiple Sclerosis TrialNCT07517185 · Recruiting · started · Sequential treatment with rituximab and cladribineSweden (4)
  3. A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple SclerosisNCT07827716 · Recruiting · started · Terfenadine; Standard First-line Disease-Modifying TherapyChina
  4. A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple SclerosisNCT07776743 · Recruiting · started · Rocbrutinib; Dimethyl FumarateChina
  5. Hyperpolarized Carbon Metabolic Imaging in Multiple SclerosisNCT07510607 · Recruiting · started · HP 13C pyruvate injection; MRI ScannerUnited States
  6. Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple SclerosisNCT07497399 · Recruiting · started · NLY01; PlaceboUnited States (3)
  7. A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)NCT07503873 · Recruiting · started · Ublituximab; Ublituximab; Prefilled penUkraine (19), Poland (10), Georgia (6), Bosnia and Herzegovina (5) and 2 more
  8. A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)NCT07282574 · Recruiting · started · RO7268489; Ocrelizumab; PlaceboSpain (20), Poland (18), Germany (17), France (11) and 8 more
  9. Cannabis (THC vs. CBD) in Multiple SclerosisNCT06261489 · Recruiting · started · THC; CBDCanada (2)
  10. PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSNCT07142291 · Recruiting · started · Cromolyn Sodium (34.2 mg BID); Cromolyn Sodium (17.1 mg BID); Placebo; Riluzole (100 mg)Spain (6), United States (5), Poland (4), Czechia (3) and 2 more
  11. A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)NCT07161258 · Recruiting · started · FenebrutinibBrazil (4), Poland (3), Spain (3), Argentina (2) and 3 more
  12. Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)NCT06463743 · Recruiting · started · metformin; PlaceboUnited States
  13. Efgartigimod for the Treatment of Acute Optic NeuritisNCT06453694 · Recruiting · started · Efgartigimod Alfa; PlaceboUnited States (2)
  14. Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)NCT06901687 · Recruiting · started · Active tDCS; Sham tDCSUnited States
  15. RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesNCT07002034 · Recruiting · started · RE104 for InjectionUnited States (32)
  16. Psilocybin Therapy for Psychological Distress in Palliative PatientsNCT06782724 · Recruiting · started · Psilocybin therapyCzechia, Denmark, Netherlands, Portugal
  17. A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityNCT06782490 · Recruiting · started · BMS-986368; PlaceboUnited States (17), Poland (11), Germany (10), Australia (8) and 3 more
  18. Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized RehabilitationNCT06956326 · Recruiting · started · Intensive rehab; Usual careDenmark (2)
  19. A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 YearsNCT06735248 · Recruiting · started · mRNA-1195; PlaceboUnited States (8), United Kingdom (8), Australia
  20. Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple SclerosisNCT06890923 · Recruiting · started · Foralumab TZLS-401 100 µgUnited States
  21. Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic SclerosisNCT06954597 · Recruiting · started · TOP-N53; Sildenafil; TOP-N53 vehicleFrance (4), Switzerland (2)
  22. BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesNCT06794008 · Recruiting · started · BCMA-CD19 CAR-T therapyChina
  23. Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote NeuroprotectionNCT06434571 · Recruiting · started · Telehealth cognitive behavioral therapy for insomnia (tCBT-I); Web-based cognitive behavioral therapy for insomnia (wCBT-I); Treatment as usual (TAU)United States
  24. Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental DisordersNCT06081348 · Recruiting · started · Sertraline; PlaceboCanada (7)
  25. MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple SclerosisNCT06592352 · Recruiting · started · Modafinil Generis 100 mgPortugal
  26. The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple SclerosisNCT06599307 · Recruiting · started · Rituximab; Saline (NaCl 0,9 %) (placebo)Egypt
  27. Solriamfetol for the Treatment of Multiple Sclerosis FatigueNCT06170970 · Recruiting · started · Solriamfetol; PlaceboUnited States
  28. Nicotinamide Riboside Supplementation In Progressive Multiple SclerosisNCT05740722 · Recruiting · started · Nicotinamid riboside; PlaceboNorway
  29. Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)NCT05418010 · Recruiting · started · Tyruko Injectable Product; PlaceboUnited Kingdom (2)
  30. Cannabis as a Complementary Treatment in Multiple SclerosisNCT05092191 · Recruiting · started · Cannabis oil vs placeboCanada
  31. Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain PhenotypeNCT05269628 · Recruiting · started · Cannabidiol (CBD); Tetrahydrocannabinol (THC); Placebo CBD; Placebo THCUnited States
  32. TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple SclerosisNCT03910738 · Recruiting · started · Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection; Placebo 4 mL Solution for Injection; MRI; Assessment of impact of MS on cognition; quality of life; fatigue; anxiety/depression and work and activitiesFrance (5)
  33. Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)NCT03888924 · Recruiting · started · Bacille Calmette-Guerin vaccine; PlaceboItaly
  34. Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)NCT02521311 · Recruiting · started · Clemastine; PlaceboUnited States
  35. Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis PlaquesNCT02784210 · Recruiting · started · Methylprednisolone; PrednisoneUnited States
  36. A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MSNCT07222956 · Not yet recruiting · started · Remibrutinib (Open Label)United States
  37. A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)NCT07503340 · Not yet recruiting · started · Ocrelizumab co-formulated with rHuPH20No sites listed yet
  38. Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (RESTOR-1)NCT07680322 · Not yet recruiting · started · AV078; PlaceboCanada
  39. Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)NCT07765212 · Not yet recruiting · started · IndapamideNo sites listed yet
  40. A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple SclerosisNCT07020715 · Not yet recruiting · started · Tolerogenic dendritic cells (tolDC)Belgium, Spain

Showing the 40 most recent of 44. See every one on ClinicalTrials.gov.

Phase 1/2 23
  1. A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple SclerosisNCT07826689 · Recruiting · started · PRO-1562 Oral Capsules; Placebo Oral CapsuleAustralia
  2. Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)NCT07287202 · Recruiting · started · SVG103Australia (2)
  3. A Study of LTX-002 in Adult Participants With Amyotrophic Lateral SclerosisNCT07660614 · Recruiting · started · LTX-002; Placebo (aCSF)Italy (2), Germany, Netherlands, Sweden
  4. MB-CART2019.1 in Refractory Multiple SclerosisNCT07178431 · Recruiting · started · MB-CART2019.1Germany
  5. Treatment of Participants With Primary or Secondary Progressive Multiple SclerosisNCT07477639 · Recruiting · started · TRX319; BendamustineUnited States (8)
  6. A Study of AZD0120 in Autoimmune DiseasesNCT07295847 · Recruiting · started · AZD0120; SOCUnited States (11), Germany (6), Spain (3), Australia (2) and 2 more
  7. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS PatientsNCT07085507 · Recruiting · started · VT7208; PlaceboAustralia
  8. First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)NCT06351592 · Recruiting · started · ALN-SOD; Diluent; Placebo (PB)Canada (4), Japan (4), Australia (3), Poland (3) and 5 more
  9. AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyNCT06063850 · Recruiting · started · AAV9-hSyn1-miGRIK2United States (18)
  10. Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple SclerosisNCT05532943 · Recruiting · started · Allogeneic umbilical cord mesenchymal stem cells; Control groupTaiwan
  11. Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyNCT05359653 · Recruiting · started · Clemastine Fumarate; PlaceboUnited States
  12. Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersNCT05395624 · Recruiting · started · 18F-OP-801United States (3)
  13. A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple SclerosisNCT04121468 · Recruiting · started · Metformin; PlaceboCanada
  14. Molecular Imaging of NET Using [C-11]MRB-PET in MSNCT03207464 · Recruiting · started · [C-11]MethylreboxetineUnited States
  15. Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)NCT03109288 · Recruiting · started · Cilostazol; Leucovorin; Pirfenidone; DantroleneUnited States
  16. PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric DiseasesNCT02649985 · Recruiting · started · [F-18]PBR06; [C-11]PBR28United States
  17. C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Progressive Multiple Sclerosis Refractory to Standard TherapyNCT07825389 · Not yet recruiting · started · C-CAR168United States (2)
  18. A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune DiseasesNCT07782450 · Not yet recruiting · started · PF-08154225No sites listed yet
  19. A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune DiseaseNCT07804004 · Not yet recruiting · started · CTX112No sites listed yet
  20. Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisNCT07756268 · Not yet recruiting · started · SYS6020 injectionChina
  21. Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair TherapyNCT06065670 · Not yet recruiting · started · Clemastine Fumarate; PlaceboUnited States
  22. Intermittent Low Oxygen Breathing: A First Study Testing Different Disease Stages in People Living With MSNCT07631143 · Not yet recruiting · started · Acute Intermittent HypoxiaNo sites listed yet
  23. A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS PatientsNCT06513546 · Not yet recruiting · started · PLL001 or placebo daily subcutaneous injectionsNo sites listed yet
Phase 1 42
  1. Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple SclerosisNCT07587125 · Recruiting · started · S103 cellsChina
  2. Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual TreatmentNCT07304154 · Recruiting · started · KITE-363; Fludarabine; CyclophosphamideUnited States (5), Canada (3), Australia (2)
  3. Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.NCT07526493 · Recruiting · started · Universal CD19 CAR-γδT Cell Injection; Cyclophosphamide; FludarabineChina
  4. Sapu003 in Advanced mTOR-sensitive Solid TumorsNCT07369505 · Recruiting · started · Sapu003; Exemestane 25 MGAustralia
  5. An Open-label Study of AZD0120 in Adults With Multiple SclerosisNCT07224373 · Recruiting · started · AZD0120 - Regimen 1; AZD0120 - Regimen 2United States (9), Australia (4), Germany (3), United Kingdom (2) and 1 more
  6. CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune DiseaseNCT07305116 · Recruiting · started · UCAR T-cellChina
  7. Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral SclerosisNCT07221240 · Recruiting · started · Amisodin; PlaceboUnited States
  8. A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisNCT07100119 · Recruiting · started · LY4256984; PlaceboCanada (5), Germany (3), Spain (2), Belgium and 1 more
  9. Obe-cel in Refractory Progressive Forms of Multiple SclerosisNCT07139743 · Recruiting · started · Obecabtagene autoleucel (obe-cel)United Kingdom (4), Spain (2), United States
  10. A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersNCT06680037 · Recruiting · started · Azercabtagene zapreleucel (azer-cel)United States (8)
  11. Exploring the Utility of [18F]3F4AP for Demyelination ImagingNCT06999434 · Recruiting · started · [ 18F]3F4AP; [18F]MK6240; [11C]PIBUnited States
  12. AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisNCT06665165 · Recruiting · started · AMX0114; PlaceboUnited States (10), Canada (4)
  13. Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple SclerosisNCT06592703 · Recruiting · started · Adipose tissue-derived Mesenchymal Stromal CellsFrance (2)
  14. Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative DiseasesNCT06671236 · Recruiting · started · Autologous Human Polyclonal Regulatory T Cells Injection (NP001 Cell Injection)China
  15. Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine LesionNCT05451251 · Recruiting · started · Deep brain stimulationCanada
  16. A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.NCT05620940 · Recruiting · started · Vivitrol Injectable Product; IVL3004; IVL4002Australia
  17. Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune DiseasesNCT07085676 · Recruiting · started · HBI0101 CARTIsrael
  18. A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple SclerosisNCT06138132 · Recruiting · started · KYV-101 anti-CD19 CAR-T cell therapy; Standard lymphodepletion regimenUnited States
  19. A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyNCT06249438 · Recruiting · started · CD20/BCMA-directed CAR-T cellsChina
  20. Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal LeukoencephalopathyNCT05849467 · Recruiting · started · 89 Zr-Df-crefmirlimabUnited States
  21. Vancomycin Study in Multiple Sclerosis (MS)NCT05539729 · Recruiting · started · Vancomycin; PlaceboUnited States
  22. Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MSNCT05003388 · Recruiting · started · cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cellsUnited States, Greece
  23. Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis SubjectsNCT04699747 · Recruiting · started · F-18 3F4APUnited States
  24. Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple SclerosisNCT02912897 · Recruiting · started · Cellular therapy with EBV specific autologous CTL infusionFrance
  25. AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple SclerosisNCT05832515 · Recruiting · started · Fludarabine Phosphate for InjectionRussia
  26. SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple SclerosisNCT03783416 · Recruiting · started · Ixazomib (NINLARO®) capsules / Matching placebo capsulesUnited Kingdom
  27. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONCT03816345 · Recruiting · started · Biospecimen Collection; Cabozantinib; Fluoropyrimidine; IpilimumabUnited States (51), Canada
  28. Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.NCT03759522 · Recruiting · started · DPA-714 PET/MRIUnited States
  29. A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of TBNNCT04667013 · Not yet recruiting · started · Tetramethylpyrazine nitrone (TBN) tablet / PlaceboNo sites listed yet
  30. C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory to Standard TherapyNCT07854483 · Not yet recruiting · started · C-CAR168United States
  31. A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple SclerosisNCT07749157 · Not yet recruiting · started · RO7845860No sites listed yet
  32. A Basket Study of CTA313 in Participants With Active Autoimmune DiseasesNCT07783269 · Not yet recruiting · started · CTA313 UCAR T Cell InfusionNo sites listed yet
  33. A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).NCT07883590 · Not yet recruiting · started · LY3873862; CYP450 Drug Cocktail; PlaceboUnited States (3), Canada
  34. A Biosimilar Trial to Investigate PK, PD, Safety With PB018 Versus US-licensed Ocrevus and EU-approved OcrevusNCT07606521 · Not yet recruiting · started · US-Ocrevus; PB018; EU-OcrevusNo sites listed yet
  35. OER Glibenclamide for Neuropathic Pain in Multiple SclerosisNCT07221799 · Not yet recruiting · started · glibenclamide; PlaceboUnited States
  36. A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyNCT07676266 · Not yet recruiting · started · CD20/BCMA-directed CAR-T cells Autologous 2nd generationChina
  37. Transcranial Magnetic Stimulation for Depression in Multiple SclerosisNCT07562074 · Not yet recruiting · started · Repetitive Transcranial Magnetic Stimulation (rTMS)Canada
  38. A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis.NCT07523100 · Not yet recruiting · started · Universal STAR-T Cell InjectionChina
  39. A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard TherapyNCT07341828 · Not yet recruiting · started · CD20/BCMA-directed CAR-T cellsNo sites listed yet
  40. Senolytics for Secondary Progressive MSNCT07270120 · Not yet recruiting · started · Dasatinib and quercetinUnited States

Showing the 40 most recent of 42. See every one on ClinicalTrials.gov.

Early phase 1 16
  1. CD19/BCMA UCAR-T for B Cell-Related Autoimmune DiseaseNCT07586267 · Recruiting · started · QT-219CXChina
  2. Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune DiseaseNCT07507201 · Recruiting · started · UCAR T-cellChina
  3. This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple SclerosisNCT07303790 · Recruiting · started · GC012F CAR-T Cell InjectionChina
  4. CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune DiseasesNCT07337785 · Recruiting · started · CD19/BCMA-targeted CAR-T cells; Lymphodepleting ConditioningChina
  5. Effects of Ublituximab on Motor Functions in Multiple SclerosisNCT06629428 · Recruiting · started · UblituximabUnited States (2)
  6. Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune DiseasesNCT06939166 · Recruiting · started · UCAR T-cellChina
  7. Assessment of Synaptic Density in MSNCT04634994 · Recruiting · started · [F-18]SDM-8United States
  8. Gait Adaptation StudyNCT07660601 · Recruiting · started · Gait Adaptation Training; Basic Physical TrainingUnited States
  9. Entire-body PET Scans for Multiple SclerosisNCT04390009 · Recruiting · started · Entire-body PET-CT scans; Amyvid radiopharmaceuticalUnited States
  10. Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemNCT04561557 · Recruiting · started · CT103A cells; Cyclophosphamide and fludarabineChina
  11. A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple SclerosisNCT07748637 · Not yet recruiting · started · GT802 InjectionChina
  12. Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDNCT07643974 · Not yet recruiting · started · Gentamicin; Lactobacillus Rhamnosus GGUnited States (2)
  13. RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune DiseasesNCT07674147 · Not yet recruiting · started · RD06-05 CART Cell InfusionChina (2)
  14. An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042 Cell Injection in the Treatment of Multiple Sclerosis (MS).NCT07546110 · Not yet recruiting · started · NK042; ofatumumabNo sites listed yet
  15. Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune DiseasesNCT07392528 · Not yet recruiting · started · QT-019CChina
  16. Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.NCT06485232 · Not yet recruiting · started · Universal BCMA CAR-T; Universal CD19 CAR-T; Universal BCMA CAR-T; Universal CD19 CAR-TChina
No phase given 234
  1. The Effects of Synchronous and Asynchronous Pilates Training Based on Telerehabilitation on Core Stabilization, Balance, Cognitive Functions, and Quality of Life in Individuals With Multiple Sclerosis: A Single-Blind Randomized Controlled TrialNCT07893925 · Recruiting · started · Synchronous Telerehabilitation-Based Pilates; Asynchronous Telerehabilitation-Based PilatesTurkey (Türkiye)
  2. High-Intensity Interval Training for Walking and Function Across Different Multiple Sclerosis Disability LevelsNCT07771868 · Recruiting · started · High-Intensity Interval TrainingTurkey (Türkiye)
  3. Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple SclerosisNCT07606742 · Recruiting · started · Exercise TrainingUnited States
  4. Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyNCT07759115 · Recruiting · started · Music Training Intervention; Music ListeningUnited States
  5. Virtual Reality - Gamma Sensory Stimulation for Improving Fatigue in People With Multiple SclerosisNCT07310862 · Recruiting · started · Virtual Reality Gamma Sensory Stimulation; Virtual Reality Sham Sensory StimulationSpain
  6. Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple SclerosisNCT07475377 · Recruiting · started · Time Restricted Eating; Unrestricted eatingUnited States
  7. Cooling During Inpatient Rehabilitation in Persons With MSNCT07852156 · Recruiting · started · Wearing a cooling vest during intensive, active training sessions; ControlSwitzerland
  8. Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNCT07573241 · Recruiting · started · MBCTUnited States
  9. OPM- MEG in Non-immune And iMmune-medIated Neurological DiseaseNCT07689682 · Recruiting · started · OPM- MagnetoencephalographyUnited Kingdom (2)
  10. Dry Needling in Multiple SclerosisNCT07615725 · Recruiting · started · Dry Needling; Sham Dry NeedlingUnited States
  11. Monitoring Intensity During Balance Training in Persons With Multiple SclerosisNCT07805850 · Recruiting · started · Balance training; SporttherapySwitzerland
  12. Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple SclerosisNCT06864936 · Recruiting · started · Ublituximab; Other disease modifying therapiesUnited States
  13. The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyNCT06796504 · Recruiting · started · Implant Procedure; Disease-Modifying Therapies (DMTs); Active stimulation; Non-active stimulationUnited States (9)
  14. Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple SclerosisNCT06919900 · Recruiting · started · Perturbation Training; Treadmill WalkingUnited States
  15. Dual-Task Training in Pediatric Multiple SclerosisNCT07571304 · Recruiting · started · Dual-Task Exercise Training; Conventional Functional Exercise TrainingTurkey (Türkiye)
  16. EXOPULSE Suit and Walking Ability of Patients With Multiple SclerosisNCT07252895 · Recruiting · started · EXOPULSE Suit in Active mode; EXOPULSE Suit in Sham modeFrance (11)
  17. At Home Use of Stimulation Suits for Managing MS SymptomsNCT07202195 · Recruiting · started · electro-stimulation suit; Usual CareBelgium, Denmark
  18. The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple SclerosisNCT07507084 · Recruiting · started · Internal Focus Dual-Task Training; External Focus Dual-Task TrainingTurkey (Türkiye)
  19. Evaluation of the Effects of Laughter YogaNCT07524231 · Recruiting · started · Laughter YogaTurkey (Türkiye)
  20. Skeletal Muscle Aging and Responsiveness in Aged People With MSNCT07500727 · Recruiting · started · Exercise trial consisting of both cardiovascular and strength trainingUnited States
  21. Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot StudyNCT07376772 · Recruiting · started · wearable focal vibration therapyUnited States (2)
  22. VR and Orthoses for Rehabilitation in Multiple SclerosisNCT07096700 · Recruiting · started · VR and walking brace-based gait rehabilitationItaly (2)
  23. Non-invasive Brain Stimulation in Multiple Sclerosis FatigueNCT07438964 · Recruiting · started · tDCS of dlPFC; Sham Stimulation of dlPFCGermany
  24. Virtual Reality Versus Mental Practice On Balance And Gait In Patients With Multiple SclerosisNCT07918339 · Recruiting · started · Mental Practice; Virtual Reality; Selected Physical Therapy ProgramEgypt
  25. Effectiveness of TMS on Spasticity and Balance for Patients With MSNCT07451600 · Recruiting · started · rTMS; sham rTMSTurkey (Türkiye)
  26. Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic DisordersNCT07509125 · Recruiting · started · UHR PET/CT scan of the brain with ¹⁸F-FDG; UHR PET/CT scan of the brain with ¹⁸F-PE2I; UHR PET/CT scan of the brain with ¹⁸F-SynVesT-1; UHR PET/CT scan of the brain with ¹⁸F-MK6240Belgium
  27. Neurorehabilitation of Cognitive Deficits in Multiple Sclerosis Using an Adaptive Cognitive ExergameNCT07086950 · Recruiting · started · Body Brain Trainer software; RehaCom softwareSwitzerland
  28. Enhancing Self-Esteem in Patients With Multiple Sclerosis: A Randomised Controlled Trial of the Lexical Association TechniqueNCT07064291 · Recruiting · started · The Lexical Association Technique (LAT); Placebo of the Lexical Association TechniqueFrance
  29. Indole-3-PROpionic Acid Clinical Trials - Multiple SclerosisNCT07318129 · Recruiting · started · Placebo; Indole-3-propionic acid (IPA)Denmark
  30. Music-Augmented Rhythmic Gait Training in Multiple SclerosisNCT07399262 · Recruiting · started · Breathing and General Mobility Exercises; Music-Assisted Rhythmic Gait Training; Rhythmic Gait Training Without MusicTurkey (Türkiye)
  31. EXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple SclerosisNCT07342777 · Recruiting · started · Progressive resistance exercise; Usual Care followed by progressive resistance exerciseDenmark
  32. Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological ExaminationNCT07135752 · Recruiting · started · Precision assessmentFrance
  33. A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) GuidelinesNCT07561957 · Recruiting · started · Use of an electronic digital ApplicationIreland (2)
  34. Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple SclerosisNCT07333222 · Recruiting · started · the Mollii garment with active stimulation; Mollii neuromodulation garment, but the stimulation program is not activated (placebo)Hungary
  35. Hesperidin RCT in MSNCT07452562 · Recruiting · started · Hesperidin; PlaceboUnited Kingdom
  36. Motor Imagery and Action Observation for Gait Function in MSNCT07137624 · Recruiting · started · Action Observation + Motor Imagery; Nature VideoTurkey (Türkiye)
  37. Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple SclerosisNCT07174973 · Recruiting · started · Balance training with FES; Balance training wiith combined neuromodulation (TSCS+FES); Balance training onlyCanada
  38. Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)NCT06280742 · Recruiting · started · PET-MRI with [18F]-DPA-714France (7)
  39. Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) PatientsNCT07392879 · Recruiting · started · Virtual Reality; Standard careUnited States
  40. Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease ActivityNCT07292480 · Recruiting · started · Monthly pNfL monitoringFrance (6)

Showing the 40 most recent of 234. See every one on ClinicalTrials.gov.

Observational, no treatment given 200
  1. Switch to Ofatumumab and Level of ImmunoglobulinsNCT07625800 · Recruiting · started · ofatumumabFrance
  2. REAL-MS: Observational Database Study of AHSCT and MS TherapiesNCT07899502 · Recruiting · started · Autologous haematopoietic stem cell transplantation (AHSCT); High-efficacy disease-modifying therapy (HE-DMT)United Kingdom (3)
  3. A Study to Describe Multiple Sclerosis Patients Treated With Tolebrutinib as Per Label in a Real-world SettingNCT07898371 · Recruiting · started · TolebrutinibUnited Arab Emirates
  4. Early Versus Delayed Start of Ocrevus Zunovo for Relapsing Multiple SclerosisNCT07878923 · Recruiting · started United States
  5. Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple SclerosisNCT07827586 · Recruiting · started · OcrelizumabCzechia, Slovenia
  6. Aerobic Fitness in Multiple Sclerosis: The Relationship Between Balance and Sensory Dual-TaskingNCT07815990 · Recruiting · started Turkey (Türkiye)
  7. Pain Phenotypes in Individuals With Multiple SclerosisNCT07766213 · Recruiting · started · Pain classification methodTurkey (Türkiye)
  8. Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.NCT07758270 · Recruiting · started · Remibrutinib; Ocrelizumab (US)United States
  9. Immun4Cure Cohort of Autoimmune DiseasesNCT07515638 · Recruiting · started · Blood test and principal collection; Optional collection; Patient questionnaires; ExaminationFrance
  10. Ocrevus Zunovo for MS: Mixed MethodsNCT07710105 · Recruiting · started · Clinical Questionnaires; Semi-Structured Interviews; Ocrevus ZunovoUnited States
  11. Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to ZeposiaNCT07732907 · Recruiting · started · OzanimodUnited States
  12. Fatigue Investigation Using Digital OutcomesNCT07783074 · Recruiting · started Switzerland (6)
  13. Auditory Functions in Patients With Multiple SclerosisNCT06164483 · Recruiting · started · Auditory test; CSF samplingItaly
  14. MRI-Based Lesion Differentiation in Older Patients With Multiple SclerosisNCT07444047 · Recruiting · started Norway
  15. Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)NCT07575347 · Recruiting · started · Observational assessmentRomania
  16. ATLG Levels in Autologous HSCT for Multiple SclerosisNCT07635693 · Recruiting · started · ATLG administrationItaly
  17. Early Detection of Selected Neuropathologies in Motor Vehicle DriversNCT07360886 · Recruiting · started Czechia
  18. Effects of Sleep Quality on Functional and Cognitive Outcomes in Multiple SclerosisNCT07536503 · Recruiting · started Turkey (Türkiye)
  19. Caregiver Burden in Caregivers of Patients With Multiple SclerosisNCT07549048 · Recruiting · started · No interventionTurkey (Türkiye)
  20. Invasive Home Ventilation in DenmarkNCT07467187 · Recruiting · started Denmark
  21. A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world PracticeNCT07779460 · Recruiting · started United States
  22. Relationship Between Single- and Dual-Task Obstacle Crossing Performance and Fatigue and Disability in Multiple SclerosisNCT07736482 · Recruiting · started Turkey (Türkiye)
  23. How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.NCT07289724 · Recruiting · started · Focus group; individual interviewFrance
  24. Investigating Specific Gait Patterns in Individuals Living With Multiple SclerosisNCT07388992 · Recruiting · started France
  25. Reliability and Validity of Three DT-TUG Protocols in MSNCT07788859 · Recruiting · started · Intra-rater reliability analysis; Inter-rater reliability analysis; Convergent validityTurkey (Türkiye)
  26. URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSISNCT07489794 · Recruiting · started Turkey (Türkiye)
  27. Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM ActivityNCT07236684 · Recruiting · started Turkey (Türkiye)
  28. The EXOPULSE Study - a Database for Routine Follow-up of Clinical OutcomesNCT05901259 · Recruiting · started · EXOPULSE Mollii Suit and EXOPULSE SuitSweden
  29. Spinal Alignment, Spinal Mobility, and Balance in Patients With Multiple SclerosisNCT07648277 · Recruiting · started Turkey (Türkiye)
  30. Gait Adaptability in Persons With MS Having Mild DisabilityNCT07580820 · Recruiting · started Belgium
  31. A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101NCT07403188 · Recruiting · started · KYV-101United States
  32. People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 AgonistsNCT07207148 · Recruiting · started · GLP-1; Ocrelizumab (US)United States
  33. Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple SclerosisNCT07505355 · Recruiting · started Spain (2), Belgium, Italy
  34. Care in Multiple Sclerosis (MS)NCT07011914 · Recruiting · started United States (6)
  35. "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MSNCT07222618 · Recruiting · started United States
  36. Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee GaitNCT07108920 · Recruiting · started · Functional clinical testsFrance
  37. Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real LifeNCT07492667 · Recruiting · started · 2017 and 2024 McDonald criteria for the diagnosis of multiple sclerosisFrance (2)
  38. "Balance, Gait, and Motion Analysis in Multiple Sclerosis"NCT07630311 · Recruiting · started Greece (2)
  39. This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.NCT07115017 · Recruiting · started · [18F] FZTAUnited States
  40. Body Awareness, Trunk Stability, and Arm Function in MSNCT07151534 · Recruiting · started Turkey (Türkiye)

Showing the 40 most recent of 200. See every one on ClinicalTrials.gov.

Source: ClinicalTrials.gov, fetched 2026-11-10.

Where to go

Institutions running these trials, by country. The country picker in the trials section narrows this list too.

🇺🇸United States775

Boston

  • Massachusetts General Hospital 6
  • Brigham and Women's Hospital 3
  • TG Therapeutics Investigational Trial Site 2
  • Brigham MS Center, 60 Fenwood Road 2
  • Beth Israel Deaconess Medical Center 2
  • Brigham & Women's Hospital 1
  • Boston Clinical Trials 1
  • Tufts Medical Center 1
  • MGH Institute of Health Professions 1
  • Massachusetts Eye and Ear Infirmary 1
  • Dana Farber Cancer Institute 1
  • Boston Clinical Trials Inc - Internal Medicine 1
  • Massachusetts General Hospital, Healey & AMG Center for ALS 1
  • Massachusetts General Hospital Cancer Center 1
  • Dana-Farber Cancer Institute 1
  • UMass Boston 1
  • Boston Children's Hospital 1

New York

  • TG Therapeutics Investigational Trial Site 3
  • NYU Langone Health 2
  • Research Site 2
  • Mount Sinai Hospital 2
  • Hunter College, Physical Therapy Department, City University of New York 2
  • Mount Sinai Medical Center 1
  • Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Siinai 1
  • Mount Sinai School of Medicine 1
  • Lange Neurology 1
  • Mt. Sinai 1
  • Columbia University Irving Medical Center 1
  • Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai 1
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone 1
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center 1
  • NYP/Weill Cornell Medical Center 1
  • Judith Jaffe Multiple Sclerosis Center 1
  • Hunter College 1
  • New York Stem Cell Foundation Research Institute 1
  • Columbia University Irving Center 1
  • New York University Medical Center 1
  • Hunter College Physical Therapy department 1

Chicago

  • Northwestern Memorial Hospital 4
  • University of Illinois at Chicago 4
  • Shirley Ryan AbilityLab 4
  • Rush University Medical Center 2
  • University of Chicago Medical Center 2
  • TG Therapeutics Investigational Trial Site 2
  • University of Illinois Chicago 2
  • University of Chicago 1
  • Local Institution - 0093 1
  • Research Site 1
  • Northwestern University 1
  • University of Chicago Comprehensive Cancer Center 1
  • Chicago Comer Children's Hospital Neurogenetic Clinic, University of Chicago 1

Bethesda

  • National Institutes of Health Clinical Center 11
  • Mid Atlantic Epilepsy and Sleep Ctr 1
  • Midatlantic Epilepsy and Sleep Center 1
  • National Cancer Institute Developmental Therapeutics Clinic 1
  • Evidera INC. 1
  • Evidera 1
  • National Institute of Neurological Disorders and Stroke 1
  • Suburban Hospital 1

Cleveland

  • Cleveland Clinic 5
  • Cleveland Clinic Foundation 3
  • TG Therapeutics Investigational Trial Site 3
  • Louis Stokes Cleveland VA Medical Center 2
  • Cleveland Clinic Ohio 1
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic 1
  • Research Site 1
  • Cleveland State University 1

St Louis

  • Washington University School of Medicine 4
  • Research Site 2
  • Washington University in St. Louis 2
  • WA Uni School Of Med 1
  • TG Therapeutics Investigational Trial Site 1
  • John L. Trotter Multiple Sclerosis Center, Washington University School of Medicine in St. Louis 1
  • Washington University School of Medicine Neurology Clinical Unit 1
  • Washington University, St. Louis 1
  • Siteman Cancer Center-South County 1
  • Siteman Cancer Center at Christian Hospital 1
  • Washington University School of Medicine in St. Louis 1
  • Barnes Jewish Center for Clinical Imaging Research 1

Kansas City

  • University of Kansas Medical Center 6
  • University of Kansas Hospital 2
  • The University of Kansas Medical Center 1
  • University of Kansas Medical Center- Sleep, Health and Wellness Laboratory 1
  • Kansas University Medical Center 1
  • University of Kansas Cancer Center 1
  • University Health Truman Medical Center 1
  • University of Kansas Cancer Center - North 1
  • Mobility and Falls Lab 1
  • Children's Mercy Research Institute 1

Columbus

  • The Ohio State University Wexner Medical Center (OSUWMC) 2
  • The Boster Center for Multiple Sclerosis 2
  • TG Therapeutics Investigational Trial Site 2
  • The Ohio State University- Site Number : 8400009 1
  • The Boster Center for Multiple Sclerosis- Site Number : 8400006 1
  • Ohio Health Research Institute 1
  • Local Institution - Site 104 1
  • The Ohio State University, Department of Psychiatry 1
  • Riverside Methodist Hospital 1
  • Local Institution - 0069 1
  • Ohio State University 1
  • Ohio State University Comprehensive Cancer Center 1
  • Ohio State Martha Morehouse Outpatient Care 1

Seattle

  • Research Site 2
  • University of Washington 2
  • Multiple Sclerosis Center at UW Medical Center - Northwest 2
  • University of Washington MS Clinic 1
  • TG Therapeutics Investigational Trial Site 1
  • Clinical Research Division, Fred Hutchinson Cancer Research Center 1
  • Multiple Sclerosis Center, Swedish Neuroscience Institute 1
  • Multiple Sclerosis Center at Northwest Hospital 1
  • Seattle Neuropsychiatric Treatment Center 1
  • Providence Swedish 1
  • Fred Hutchinson Cancer Center 1
  • UW Medicine Multiple Sclerosis Center-Northwest 1

Birmingham

  • University of Alabama at Birmingham 4
  • Alabama Neurology Associates 2
  • TG Therapeutics Investigational Trial Site 2
  • Alabama Neurology Associates PC 1
  • UAB, Psychiatry and Behavioral Neurology 1
  • University of Alabama at Birmingham Cancer Center 1
  • University of Alabama at Birmingham Medical Center 1
  • University of Alabama Birmingham 1

Houston

  • The University of Texas Health Science Center at Houston 3
  • Neuro-Eye Clinical Trials 1
  • TG Therapeutics Investigational Trial Site 1
  • Maxine Mesigner Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine Medical Center 1
  • Houston Methodist Neurological Institute 1
  • UT MD Anderson Cancer Center 1
  • Houston Methodist Hospital 1
  • Baylor College of Medicine 1
  • The University of Texas Health Science Center at Houston (UTHealth Houston) 1
  • Texas Childrens Hospital Baylor College of Medicine 1
  • Memorial Hermann-Texas Medical Center (University of Texas Houston) 1

Atlanta

  • Atlanta Neuroscience Institute 2
  • TG Therapeutics Investigational Trial Site 2
  • Atlanta Neuroscience Institute- Site Number : 8400075 1
  • Local Institution - Site 102 1
  • Emory University 1
  • Emory University Hospital/Winship Cancer Institute 1
  • Georgia State University 1
  • Shepherd Center 1
  • Georgia State University Biomechanics Lab 1
  • Emory Univeristy 1

Baltimore

  • Johns Hopkins University 3
  • Johns Hopkins School of Medicine 2
  • Baltimore Veterans Affairs Medical Center- Site Number : 8400163 1
  • Research Site 1
  • Pharmaron, Inc. 1
  • Johns Hopkins University/Sidney Kimmel Cancer Center 1
  • University of Maryland School of Medicine 1
  • University of Maryland, Baltimore 1
  • TG Therapeutics Investigational Trial Site 1

Aurora

  • University of Colorado Anschutz Medical Campus 2
  • Rocky Mountain Regional VA Medical Center- Site Number : 8400121 1
  • UC Health Neuroscience Ctr 1
  • Rocky Mountain Multiple Sclerosis Center, University of Colorado School of Medicine 1
  • University of Colorado 1
  • Local Institution - 0017 1
  • Research Site 1
  • University of Colorado Anschutz 1
  • Rocky Mountain Regional VA Medical Center, Aurora, CO 1
  • University of Colorado Denver 1
  • TG Therapeutics Investigational Trial Site 1

Tampa

  • University of South Florida Department of Neurology - MS Division 2
  • University Of South Florida 2
  • University of South Florida 2
  • University of South Florida- Site Number : 8400013 1
  • Axiom Brain Health 1
  • TG Therapeutics Investigational Trial Site 1
  • Local Institution - Site 103 1
  • University of South Florida, Department of Psychiatry and Behavioral Neuroscience 1
  • USF Health 1

Milwaukee

  • Medical College of Wisconsin 6
  • TG Therapeutics Investigational Trial Site 3
  • Medical College of Wisconsin - Milwaukee Campus- Site Number : 8400038 1
  • Research Site 1
  • Marquette University 1

Dallas

  • UT Southwestern Medical Center (Ophthalmology CRU) 1
  • Carum Research 1
  • Univ of Texas Southwest Med Center 1
  • University of Texas Southwestern Medical Center: Division of Multiple Sclerosis and Neuroimmunology 1
  • Local Institution - Site 107 1
  • University of Texas Southwestern Medical Center 1
  • UT Southwestern Simmons Cancer Center - RedBird 1
  • UT Southwestern/Simmons Cancer Center-Dallas 1
  • TG Therapeutics Investigational Trial Site 1
  • Scottish Rite Hospital for Children 1
  • UT Southwestern Medical Center 1

San Francisco

  • University of California San Francisco 2
  • Sandler Neurosciences Building, Neurological Clinical Research Unit 2
  • University of California, San Francisco 2
  • Byers Hall 1
  • Sutter Health - California Pacific Medical Center Research Institute 1
  • UCSF 1
  • Sutter Health Research Institute- California Pacific Medical Center, Van Ness Campus 1
  • University of California-San Francisco 1

Washington D.C.

  • TG Therapeutics Investigational Trial Site 2
  • Georgetown University Hospital 1
  • Medstar Washington Hosp Ctr 1
  • Medstar Washington Hospital Center 1
  • Research Site 1
  • Georgetown University Hospital Pasquerilla Healthcare Center 1
  • MedStar Georgetown University Hospital 1
  • MedStar National Rehabilitation Hospital 1

Cincinnati

  • TG Therapeutics Investigational Trial Site 2
  • Cincinnati Children's Hospital Medical Center 2
  • Univ of Cincinnati Medical Center 1
  • Local Institution - 0091 1
  • University of Cincinnati (UC) Waddell Center for Multiple Sclerosis 1
  • University of Cincinnati Medical Center 1
  • University of Cincinnati 1

Scottsdale

  • Perseverance Research Center 2
  • Clinical Endpoints, LLC 1
  • Perseverance Research Center, LLC (PRC) 1
  • Perseverance Research Center- Site Number : 8400138 1
  • Honor Health Neurology - Bob Bove Neuroscience Institute 1
  • Perseverance Research Center,LLC 1
  • TG Therapeutics Investigational Trial Site 1

Orlando

  • Orlando Health Clinical Trials 2
  • Neurological Services of Orlando 1
  • Orlando Health Neuroscience Institute - Downtown Pavilion- Site Number : 8400060 1
  • Comprehensive Neurology Clinic 1
  • Advent Health Orlando 1
  • Orlando Regional Medical Center, Orlando Health Neuroscience Institute 1
  • TG Therapeutics Investigational Trial Site 1

Austin

  • The University of Texas at Austin 3
  • Austin Regional Clinic 1
  • Dell Medical School, University of Texas at Austin 1
  • Baylor Scott & White Medical Center 1
  • University of Texas at Austin 1
  • TG Therapeutics Investigational Trial Site 1

Rochester

  • Mayo Clinic 3
  • Mayo Clinic in Rochester 2
  • Rochester Multiple Sclerosis Center, University of Rochester 1
  • TG Therapeutics Investigational Trial Site 1
  • University of Rochester Medical Center 1

Philadelphia

  • University of Pennsylvania 2
  • Penn Comprehensive MS Center, Hospital of the University of Pennsylvania 1
  • Thomas Jefferson University, Jefferson Headache Center 1
  • Hospital of the University of Pennsylvania 1
  • Temple University of the Commonwealth System of Higher Education 1
  • Thomas Jefferson University Hospital 1
  • University of Pennsylvania Medical Center 1

Raleigh

  • Velocity Clinical Research 2
  • TG Therapeutics Investigational Trial Site 2
  • Velocity Clinical Research, Raleigh Neurology 1
  • Raleigh Neurology Associates- Site Number : 8400014 1
  • Local Institution - Site 101 1

Phoenix

  • Arizona Neuroscience Research, LLC 1
  • Center for Neurology and Spine - Phoenix - East Bell Road- Site Number : 8400195 1
  • Xenoscience Inc 1
  • Ctr for Neurology and Spine 1
  • AZ Integrated Neuro and Spine 1
  • Mayo Clinic Arizona 1
  • TG Therapeutics Investigational Trial Site 1

Naples

  • Aqualane Clinical Research 4
  • Aqualane Clinical Research- Site Number : 8400026 1
  • Prodromos Stem Cell Institute 1
  • TG Therapeutics Investigational Trial Site 1

Gainesville

  • University of Florida 3
  • Norman Fixel Institute for Neurological Diseases (FIND)- Site Number : 8400054 1
  • UF Health Cancer Center 1
  • Norman Fixel Institute for Neurological Diseases 1
  • TG Therapeutics Investigational Trial Site 1

Knoxville

  • TG Therapeutics Investigational Trial Site 2
  • Hope Neurology- Site Number : 8400019 1
  • Sibyl Wray MD Neurology PC 1
  • Alliance for Multispecialty Research Clinical 1
  • Hope Neurology 1
  • Alliance for Multispecialty Research, LLC 1

Miami

  • Miami NS Ins Baptist Health S FL 1
  • Elite Clinical Research 1
  • University of Miami Hospital & Clinics - Sylvester Comprehensive Cancer Center - Neurology 1
  • Bascom Palmer Eye Institute 1
  • TG Therapeutics Investigational Trial Site 1
  • Andrey Vyshedskiy 1
  • Nicklaus Children's Hospital 1

La Jolla

  • University of California San Diego 1
  • UC San Diego 1
  • Research Site 1
  • TG Therapeutics Investigational Trial Site 1
  • University of California, San Diego 1
  • University of California San Diego OTIS 1
  • Novartis Investigative Site 1

Maitland

  • Neurology Associates, PA 2
  • Neurology Associates PA 2
  • Neurology Associates 1
  • TG Therapeutics Investigational Trial Site 1

Oklahoma City

  • Oklahoma Medical Research Foundation 2
  • OMRF Multiple Sclerosis Center of Excellence 1
  • TG Therapeutics Investigational Trial Site 1
  • Local Institution - Site 105 1
  • Oklahoma Medical Research Foundation (OMRF) MS Center of Excellence 1

Foxborough

  • Neurology Center of New England- Site Number : 8400164 1
  • Neuro Institute of New England P C 1
  • Neurology Center of New England PC 1
  • TG Therapeutics Investigational Trial Site 1
  • Neurology Center of New England 1
  • Neurology Center of New England P.C. 1

Palo Alto

  • Stanford Multiple Sclerosis Center 2
  • Stanford University 2
  • Stanford Neuroscience Health Center 1
  • Stanford Cancer Institute Palo Alto 1

Ann Arbor

  • University of Michigan 3
  • TG Therapeutics Investigational Trial Site 2
  • Research Site 1

West Hollywood

  • Regina Berkovich MD, PhD Inc. 1
  • Regina Berkovich MD, PhD Inc 1
  • Private Practice - Dr. Regina Berkovich- Site Number : 8400005 1
  • Regina Berkovich MD PhD Inc 1
  • TG Therapeutics Investigational Trial Site 1

Greenville

  • Premier Neurology 4
  • TG Therapeutics Investigational Trial Site 1

Tucson

  • Research Site 2
  • Center for Neurosciences - Tucson- Site Number : 8400194 1
  • Center for Neurosciences 1
  • University of Arizona 1

Plano

  • North Texas Institute of Neurology & Headache - Plano- Site Number : 8400082 1
  • North Texas Institute of Neurology & Headache - Plano- Site Number : 8400083 1
  • Saturn Research Solution 1
  • Saturn Research Solutions LLC 1
  • Saturn Research Solutions 1

Salt Lake City

  • TG Therapeutics Investigational Trial Site 3
  • LDS Hospital - Intermountain Health 1
  • Huntsman Cancer Institute/University of Utah 1

Detroit

  • Henry Ford Neuroscience Institute 1
  • Wayne State University/Karmanos Cancer Institute 1
  • John D. Dingell VA Medical Center 1
  • TG Therapeutics Investigational Trial Site 1
  • Wayne State University 1

Pittsburgh

  • University of Pittsburgh 2
  • Allegheny Health Network 1
  • UPMC Hillman Cancer Center 1
  • University of Pittsburgh Medical Center 1

Fort Collins

  • Advanced Neurology of Colorado, LLC 1
  • Advanced Neurology of Colorado- Site Number : 8400148 1
  • TG Investigational Site 1
  • TG Therapeutics Investigational Trial Site 1

Cordova

  • Neurology Clinic PC 2
  • Neurology Clinic, P.C. 2

San Antonio

  • Lone Star Neurology 2
  • Neurology Center of San Antonio- Site Number : 8400099 1
  • TG Therapeutics Investigational Trial Site 1

Albuquerque

  • University Of New Mexico School Of Medicine 1
  • University of New Mexico Hospital 1
  • University of New Mexico 1
  • University of New Mexico, School of Medicine 1

Altamonte Springs

  • Neurology of Central FL Res Ctr 2
  • Neurology of Central Florida- Site Number : 8400147 1
  • TG Therapeutics Investigational Trial Site 1

Farmington Hills

  • Michigan Institute of Neurological 2
  • Michigan Institute for Neurological Disorders- Site Number : 8400004 1
  • Quest Research Institute 1

Teaneck

  • Holy Name Medical Center- Site Number : 8400101 1
  • Holy Name Medical Center 1
  • Local Institution - 0132 1
  • TG Therapeutics Investigational Trial Site 1

Charlotte

  • Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002 1
  • Atrium Health 1
  • TG Therapeutics Investigational Trial SiteCharlotte 1
  • TG Therapeutics Investigational Trial Site 1

Buffalo

  • SUNY Buffalo The Jacobs Neuro Inst 1
  • UBMD Neurolgy 1
  • Roswell Park Center Institute 1
  • Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo 1

Portland

  • Providence Neurological Services West 1
  • Local Institution - 0092 1
  • Multiple Sclerosis Center, Oregon Health & Science University 1
  • TG Therapeutics Investigational Trial Site 1

Durham

  • Duke University Medical Center 2
  • Duke University 1
  • IQVIA US Office 1

Jacksonville

  • Mayo Clinic Jacksonville 2
  • Mayo Clinic Florida 1
  • Mayo Clinic in Florida 1

Savannah

  • TG Therapeutics Investigational Trial Site 2
  • Savannah Neurology Specialists,PC 1

Las Vegas

  • Cleveland Clinic 1
  • Cleveland Clinic Foundation 1
  • TG Therapeutics Investigational Trial Site 1

Roeland Park

  • KC Research Center, PA Neurology Research Department 1
  • KC Research Center, PA Neurology Research Dept 1
  • TG Therapeutics Investigational Trial Site 1

Boca Raton

  • SFM Clinical Research, LLC 1
  • UHealth Boca Raton 1
  • TG Therapeutics Investigational Trial Site 1

Indianapolis

  • Josephson Wallack Munshower Neurology, Pc Suite 225 1
  • TG Therapeutics Investigational Trial Site 1
  • Rehabilitation Hospital of Indiana 1

Worcester

  • University of Massachusetts Memorial Medical Center 2
  • University of Massachusetts Chan Medical Center 1

Cullman

  • TG Therapeutics Investigational Trial Site 2
  • North Central Neurology Associates- Site Number : 8401100 1

Smyrna

  • Joi Life Wellness Group Llc- Site Number : 8400192 1
  • Joi Life Wellness Group LLC 1
  • TG Therapeutics Investigational Trial Site 1

El Paso

  • ANESC Research- Site Number : 8400187 1
  • Local Institution - 0133 1
  • ANESC Research 1

Newport Beach

  • Hoag Memorial Hospital Presbyterian 2
  • TG Therapeutics Investigational Trial Site 1

Honolulu

  • Hawaii Pacific Neuroscience LLC 1
  • Hawaii Pacific Neuroscience 1
  • TG Therapeutics Investigational Trial Site 1

Chapel Hill

  • University of North Carolina 1
  • University of North Carolina at Chapel Hill 1
  • Research Site 1

Richmond

  • Virginia Commonwealth University 1
  • Virginia Commonwealth University Multiple Sclerosis Treatment and Research Center 1
  • VCU Massey Comprehensive Cancer Center 1

New Brunswick

  • Local Institution - 0131 1
  • Robert Wood Johnson Hospital 1
  • Rutgers Cancer Institute of New Jersey 1

Iowa City

  • TG Therapeutics Investigational Trial Site 1
  • UI Health Care 1
  • University of Iowa Hospitals and Clinics 1

Overland Park

  • TG Therapeutics Investigational Trial Site 1
  • University of Kansas Cancer Center-Overland Park 1
  • University of Kansas Hospital-Indian Creek Campus 1

Farmington

  • TG Investigational Site 1
  • Local Institution - 0080 1
  • TG Therapeutics Investigational Trial Site 1

Plymouth

  • TG Therapeutics Investigational Trial Site 2
  • Minnesota Center for Multiple Sclerosis 1

Kirkland

  • TG Therapeutics Investigational Trial Site 2
  • EvergreenHealth Medical Center 1

Charlottesville

  • University of Virginia 1
  • UVA Center for Psychiatric Clinical Research 1
  • TG Therapeutics Investigational Trial Site 1

Omaha

  • TG Therapeutics Investigational Trial Site 2
  • University of Nebraska Medical Center 1

Gilbert

  • Research Site 2
  • TG Therapeutics Investigational Trial Site 1

New Haven

  • Yale University PET Center 1
  • Smilow Cancer Center/Yale-New Haven Hospital 1
  • Yale University 1

Richardson

  • UT Southwestern Clinical Center at Richardson/Plano 1
  • The University of Texas at Dallas 1
  • Callier Clinical Researcher Center 1

Los Angeles

  • Cedars-Sinai Medical Center 2
  • University of California Los Angeles 1

Urbana

  • Disability Participation and Quality of Life (DPQOL) Laboratory 1
  • University of Illinois Urbana-Champaign 1
  • TG Therapeutics Investigational Trial Site 1

East Hanover

  • Kessler Foundation 2
  • Novartis 1

Denver

  • University of Colorado, Denver 1
  • TG Therapeutics Investigational Trial Site 1
  • The Children's Hospital 1

Bradenton

  • Nova Clinical Research, LLC 2

Livingston

  • Cooperman Barnabas Medical Center 1
  • TG Therapeutics Investigational Trial Site 1

Sherman

  • Texas Institute for Neurological Disorders - Sherman 2

Fullerton

  • Fullerton Neurology and Headache Center 1
  • Fullerton Neuro and Headache Ctr 1

Clearwater

  • MS and Neuromuscular Center of Excellence 1
  • TG Therapeutics Investigational Trial Site 1

Rochester Hills

  • Profound Research LLC at Oakland Neurology Center 1
  • TG Therapeutics Investigational Trial Site 1

Ormond Beach

  • Neurology Associates of Ormond Beach- Site Number : 8400086 1
  • Neurology Associates of Ormond Beach 1

Wellesley

  • Elliot Lewis MS Center 1
  • TG Therapeutics Investigational Trial Site 1

Nashville

  • Vanderbilt Breast Center at One Hundred Oaks 1
  • TG Therapeutics Investigational Trial Site 1

Spokane

  • Citta Clinical Research 1
  • TG Therapeutics Investigational Trial Site 1

Irvine

  • University of California Irvine 1
  • University of California Irvine Center for Clinical Research 1

Burlington

  • Lahey Hospital and Medical Center 1
  • TG Therapeutics Investigational Trial Site 1

Owosso

  • Memorial HC Ins for Neuroscience 1
  • TG Therapeutics Investigational Trial Site 1

Centerville

  • Premier Health 1
  • TG Therapeutics Investigational Trial Site 1

Fort Worth

  • John Peter Smith Hospital 1
  • UT Southwestern/Simmons Cancer Center-Fort Worth 1

Greenfield

  • Center for Neurological Disorders G 1
  • TG Therapeutics Investigational Trial Site 1

Loma Linda

  • Local Institution - 0114 1
  • Loma Linda University Children's Hospital 1

Sacramento

  • University of California Davis Health 1
  • University of California Davis Comprehensive Cancer Center 1

Louisville

  • University of Louisville, Norton Children's Research Institute 1
  • TG Therapeutics Investigational Trial Site 1

Orange

  • TG Therapeutics Investigational Trial Site 2

Golden Valley

  • TG Therapeutics Investigational Trial Site 2

Dayton

  • TG Therapeutics Investigational Trial Site 1
  • University of Dayton 1

Vienna

  • TG Therapeutics Investigational Trial Site 2

Evanston

  • Northwestern University 1
  • TG Therapeutics Investigational Trial Site 1

Stanford

  • Research Site 1
  • Stanford University 1

Lebanon

  • Dartmouth Hitchcock Medical Center 1
  • Dartmouth-Health Lebanon 1

Lexington

  • University of Kentucky/Markey Cancer Center 1
  • TG Therapeutics Investigational Trial Site 1

Morgantown

  • West Virginia University 1
  • TG Therapeutics Investigational Trial Site 1

Pomona

  • Casa Colina Hospital and Centers for Healthcare 2

Cherry Hill

  • Multiple Sclerosis Association of America 1
  • TG Therapeutics Investigational Trial Site 1

North Haven

  • Yale MS Clinic 1
  • Yale University 1

Memphis

  • St. Jude Children's Research Hospital 1
  • Le Bonheur Children's Hospital 1

Morristown

  • Atlantic Health 1

Centennial

  • Amerita 1

Livonia

  • Kahana Oculoplastic and Orbital Surgery 1

Charleston

  • Medical University of South Carolina, Storm Eye Institute 1

Pheonix

  • Arizona Neuroscience Research, LLC 1

Torrance

  • Harbor-UCLA Medical Center - The Lundquist Institute (Los Angeles Biomedical Research Institute (LA BioMed)) 1

Homewood

  • Alabama Neurology Associates- Site Number : 8400115 1

Lancaster

  • Chemidox Clinical Trials- Site Number : 8401157 1

West Palm Beach

  • Palm Beach Neurology- Site Number : 8400105 1

Northbrook

  • Consultants in Neurology- Site Number : 8400020 1

Abington

  • Abington Neurological Associates- Site Number : 8401065 1

Homestead

  • Homestead Assoc In Research Inc 1

Frederick

  • Clinre Comprehensive Neurology 1

Worchester

  • U Mass Memorial Medical Center 1

Hollywood

  • Memorial Healthcare System 1

Tallahassee

  • Tallahassee Neurological Clinic 1

Vero Beach

  • Vero Beach Neurology 1

Olney

  • MedStar Montgomery Medical Center 1

Fargo

  • Sanford Health 1

Lutherville

  • TG Therapeutics Investigational Trial Site 1

North Worcester

  • TG Therapeutics Investigational Trial Site 1

Minneapolis

  • University of Minnesota Multiple Sclerosis Center 1

Stony Brook

  • Local Institution - Site 106 1

San Diego

  • Kadima Neuropsychiatry Institute 1

Santa Rosa

  • Providence Medical Foundation 1

Shreveport

  • LSU Health Shreveport 1

Rockville

  • Sunstone Therapies, PC 1

Towson

  • Sheppard Pratt 1

Novi

  • Henry Ford Health 1

Draper

  • Cedar Clinical Research Inc. 1

Madison

  • University of Wisconsin at Madison 1

Southfield

  • Northwest Neurology 1

Lewisville

  • Prime Clinical Research 1

Ozark

  • Sharlin Health & Neurology 1

Duarte

  • Research Site 1

Grand Rapids

  • Corewell Health 1

Hackensack

  • Northeast Regional Epilepsy Group 1

Fairway

  • University of Kansas Clinical Research Center 1

Hays

  • HaysMed 1

Lawrence

  • Lawrence Memorial Hospital 1

Olathe

  • The University of Kansas Cancer Center - Olathe 1

Pittsburg

  • Mercy Hospital Pittsburg 1

Salina

  • Salina Regional Health Center 1

Topeka

  • University of Kansas Health System Saint Francis Campus 1

Westwood

  • University of Kansas Hospital-Westwood Cancer Center 1

City of Saint Peters

  • Siteman Cancer Center at Saint Peters Hospital 1

Creve Coeur

  • Siteman Cancer Center at West County Hospital 1

Lee's Summit

  • University of Kansas Cancer Center - Lee's Summit 1

North Kansas City

  • University of Kansas Cancer Center at North Kansas City Hospital 1

Mineola

  • NYU Langone Hospital - Long Island 1

Newark

  • Stanley Bergen Building 1

Ladera Ranch

  • Brain Health Alliance 1

Saint Augustine

  • University of St. Augustine for Health Sciences 1

Boulder

  • University of Colorado 1

Champaign

  • University of Illinois Urbana-Champaign 1

West Orange

  • Kessler Foundation 1

Westport

  • MD Stem Cells 1

Coral Springs

  • MD Stem Cells 1

Decatur

  • Atlanta VA Medical and Rehab Center, Decatur, GA 1

Lawrenceville

  • Bristol Myers Squibb 1

Huntsville

  • TG Therapeutics Investigational Trial Site 1

Mobile

  • TG Therapeutics Investigational Trial Site 1

Fresno

  • TG Therapeutics Investigational Trial Site 1

Basalt

  • TG Therapeutics Investigational Trial Site 1

Colorado Springs

  • TG Therapeutics Investigational Trial Site 1

Grand Junction

  • TG Therapeutics Investigational Trial Site 1

Hartford

  • TG Therapeutics Investigational Trial Site 1

Pensacola

  • TG Therapeutics Investigational Trial Site 1

Weston

  • TG Therapeutics Investigational Trial Site 1

Coeur d'Alene

  • TG Therapeutics Investigational Trial Site 1

Avon

  • TG Therapeutics Investigational Trial Site 1

Glen Burnie

  • TG Therapeutics Investigational Trial Site 1

Norfolk

  • TG Therapeutics Investigational Trial Site 1

Billings

  • TG Therapeutics Investigational Trial Site 1

Lincoln

  • TG Therapeutics Investigational Trial Site 1

Bridgewater

  • TG Therapeutics Investigational Trial Site 1

Freehold

  • TG Therapeutics Investigational Trial Site 1

Neptune City

  • TG Therapeutics Investigational Trial Site 1

Paramus

  • TG Therapeutics Investigational Trial Site 1

Amherst

  • TG Therapeutics Investigational Trial Site 1

Lake Success

  • TG Therapeutics Investigational Trial Site 1

The Bronx

  • TG Therapeutics Investigational Trial Site 1

New Bern

  • TG Therapeutics Investigational Trial Site 1

Toledo

  • TG Therapeutics Investigational Trial Site 1

Norman

  • TG Therapeutics Investigational Trial Site 1

Bethlehem

  • TG Therapeutics Investigational Trial Site 1

Franklin

  • TG Therapeutics Investigational Trial Site 1

Mount Juliet

  • TG Therapeutics Investigational Trial Site 1

Spring Hill

  • TG Therapeutics Investigational Trial Site 1

Edinburg

  • TG Therapeutics Investigational Trial Site 1

Frisco

  • TG Therapeutics Investigational Trial Site 1

Lubbock

  • TG Therapeutics Investigational Trial Site 1

Ogden

  • TG Therapeutics Investigational Trial Site 1

Salem

  • TG Therapeutics Investigational Trial Site 1

Virginia Beach

  • TG Therapeutics Investigational Trial Site 1

Neenah

  • TG Therapeutics Investigational Trial Site 1

Waukesha

  • TG Therapeutics Investigational Trial Site 1

Wilmington

  • BRIUMVI® Pregnancy Registry Virtual Research Coordination Center 1

Delafield

  • Brain Inflammation Collaborative 1

Oakland

  • Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center 1

Silver Spring

  • TSC Alliance 1

Roseville

  • Minnesota Epilepsy Group 1

Fairfax

  • Children's National Medical Center 1

Waltham

  • Accelerated Cure Project 1

Kenmore

  • Bastyr University Clinical Research Center 1
🇩🇪Germany327

Berlin

  • Novartis Investigative Site 2
  • Charité Universitätsmedizin Berlin 2
  • Charité Universitaetsmedizin Berlin - Campus Ch 1
  • Charité Centrum für Neurologie, Neurochirurgie und Psychiatrie 1
  • Research Site 1
  • Charité Campus Mitte 1
  • Department for integrative medicine and prevention, Institute for social medicine, epidemiology and health economics, Charité university medicine Berlin 1
  • Neurologisches Facharztzentrum Berlin am Sankt Gertrauden-Krankenhaus 1
  • NEUROZENTRUM tempelhof.berlin 1
  • Praxis Dr. Said Masri 1
  • Jüdisches Krankenhaus Berlin 1
  • NeuroZentrum Zehlendorf Dr. Ringel und Dr. Scherer 1
  • Neurologisches Zentrum für Bewegungsstörungen und Diagnostik 1
  • ERC Charité - Universitätsmedizin Berlin 1

Düsseldorf

  • Heinrich-Heine University, Duesseldorf 2
  • Universitaetsklinikum Duesseldorf 1
  • University Hospital Düsseldorf 1
  • Gemeinschaftspraxis für Neurologie 1
  • Universitätsklinikum Düsseldorf 1
  • Nervenarztpraxis Gerresheim 1
  • University Hospital Düsseldorf, Department of Neurology 1
  • Medical Faculty, Heinrich-Heine-University 1
  • Novartis Investigative Site 1

Ulm

  • Novartis Investigative Site 2
  • NeuroPoint Gesellschaft fur vorbeugende Gesundheitspflege mbH 1
  • Studienzentrum Neuropoint GmbH, 1
  • Universitaetsklinikum Ulm 1
  • Universitaetsklinikum Ulm AoR 1
  • Universitätsklinikum Ulm 1
  • University Hospital Ulm, Dept. of Neurology 1
  • Nervenfachaerztliche Gemeinschaftspraxis Ulm 1

Bochum

  • Novartis Investigative Site 2
  • St. Josef-Hospital Universitaetsklinikum 1
  • St. Josef und St. Elisabeth Hospital gGmbH 1
  • St. Josef-Hospital 1
  • Katholisches Klinikum Bochum - St. Joseph-Hospital 1
  • Katholisches Klinikum Bochum 1

Leipzig

  • Novartis Investigative Site 2
  • Universitaetsklinikum Leipzig 1
  • Research Site 1
  • Arztpraxis Dr. med. Torsten Sühnel 1
  • Neurologische Praxis Dr. Ehrlich 1

Essen

  • Novartis Investigative Site 2
  • Universitaetsklinkm Essen 1
  • Local Institution - 0020 1
  • Zentrum für ambulante Neurologie / Praxis Knorn Landefeld Friedrich 1
  • Praxis Nervenstark 1

Mannheim

  • Novartis Investigative Site 2
  • Universitaetsmedizin Mannheim 1
  • Neuroplus Dres. Lennart Thilmann/ Patrick Thilmann 1
  • Universitätsklinikum Mannheim 1

Munich

  • Novartis Investigative Site 2
  • LMU-Campus Grosshadern 1
  • Klinikum rechts der Isar der TU Muenchen 1
  • Technical University of Munich 1

Jena

  • Novartis Investigative Site 2
  • Universitätsklinikum Jena 1
  • Research Site 1
  • Universitätsklinikum Jena, Klinik für Neurologie 1

Münster

  • Novartis Investigative Site 2
  • Universitätsklinikum Münster - Albert Schweitzer Campus 1
  • Universitätsklinikum Münster 1
  • Herz-Jesu-Krankenhaus Hiltrup GmbH 1

Hamburg

  • Universitaetsklinikum Hamburg-Eppendorf 1
  • Research Site 1
  • Universiätsklinikum Hamburg-Eppendorf 1
  • Neurologische Praxis Eppendorf 1
  • Novartis Investigative Site 1

Erbach im Odenwald

  • Novartis Investigative Site 3
  • Neuro Centrum Science Gmbh Albert-Schwitzer 1

Tübingen

  • Novartis Investigative Site 2
  • Universitaetsklinikum Tuebingen 1
  • Universitätsklinikum Tübingen, Zentrum für Neurologie 1

Erlangen

  • Universitaetsklinikum Erlangen 1
  • Research Site 1
  • Universitätsklinikum Erlangen, Neurologische Klinik 1
  • Novartis Investigative Site 1

Lübeck

  • Universitaetsklinikum Schleswig-Holstein 1
  • University Hospital Schleswig-Holstein, Campus Lübeck 1
  • Universitätsklinikum Schleswig-Holstein 1
  • Universitätsklinik Schleswig Holstein, Campus Lübeck 1

Siegen

  • Local Institution - 0078 1
  • Gemeinschaftspraxis für Neurologie, Psychiatrie und Psychotherapie 1
  • Praxis für Neurologie und Psychiatrie 1
  • Novartis Investigative Site 1

Magdeburg

  • Research Site 1
  • Neurologie im Ulrichshaus Magdeburg 1
  • Universitätsklinikum Magdeburg 1
  • Novartis Investigative Site 1

München

  • Neurologie München Nord 1
  • Klinikum rechts der Isar der TU München 1
  • Praxis für Neurologie und Psychiatrie am Prinzregentenplatz 1
  • Novartis Investigative Site 1

Stuttgart

  • Praxis Dr. med. Andreas Kowalik, Arzt für Neurologie und Psychiatrie 1
  • Neuropraxis Sotiriadis 1
  • Neurozentrum Stuttgart Mitte Sophienstraße 1
  • Novartis Investigative Site 1

Bad Homburg

  • Zentrum fur klinische Forschung Dr.Scholl GmbH 2
  • Novartis Investigative Site 1

Freiburg im Breisgau

  • Novartis Investigative Site 1
  • Universitaetsklinikum Freiburg 1
  • Universitätsklinikum Freiburg, Klinik für Neurologie und Neurophysiologie 1

Unterhaching

  • Novartis Investigative Site 2
  • Neuropraxis München Süd 1

Halle

  • Novartis Investigative Site 2
  • Krankenhaus Martha-Maria Halle-Doelau 1

Giessen

  • Novartis Investigative Site 2
  • Universitätsklinikum Gießen und Marburg GmbH 1

Marburg

  • Novartis Investigative Site 2
  • Universitätsklinikum Giessen und Marburg 1

Dresden

  • Universitaetsklinikum Carl Gustav Carus TU Dresden 1
  • Universitaetsklinikum Carl Gustav Carus Dresden 1
  • Novartis Investigative Site 1

Hanover

  • DIAKOVERE Henriettenstift - Klinik für Neurologie und Klinische Neurophysiologie 1
  • Neurologische Praxis 1
  • Novartis Investigative Site 1

Würzburg

  • Research Site 2
  • Klinikum Würzburg Mitte 1

Nuremberg

  • Gemeinschaftspraxis Uhlig und Windsheimer 1
  • Neurologie Nürnberg-Eibach 1
  • Novartis Investigative Site 1

Erfurt

  • Novartis Investigative Site 2

Greifswald

  • Novartis Investigative Site 2

Heidelberg

  • Novartis Investigative Site 2

Ibbenbueren

  • Novartis Investigative Site 1
  • Klinikum Ibbenbüren gmbH 1

Itzehoe

  • Novartis Investigative Site 2

Wiesbaden

  • Novartis Investigative Site 1
  • Deutsche Klinik für Diagnostik 1

Bremen

  • Gesundheit Nord, Klinikum Bremen-Ost 1
  • Novartis Investigative Site 1

Frankfurt am Main

  • Universitaetsklinikum Frankfurt Goethe-Universitaet 1
  • Novartis Investigative Site 1

Bonn

  • Universitaetsklinikum Bonn AoeR 1
  • Novartis Investigative Site 1

Rostock

  • Universitätsmedizin Rostock Sektion für Translationale Neurodegeneration "Albrecht Kossel" Klinik und Poliklinik für Neurologie 1
  • Novartis Investigative Site 1

Bamberg

  • Neurologische Praxis - Kallmann Neurologie - mszb 1
  • Novartis Investigative Site 1

Bogen

  • Dres. Lippert/Kausch 1
  • Novartis Investigative Site 1

Celle

  • Allgemeines Krankenhaus Celle / Klinik für Neurologie 1
  • Neuropraxis Celle: Praxis für Neurologie & Psychatrie 1

Chemnitz

  • Praxisgemeinschaft Dres. Sylke Domke und Vasil Gjaurov 1
  • Novartis Investigative Site 1

Cologne

  • NeuroMed Campus Neurologische Gemeinschaftspraxis am St. Elisabeth Krankenhaus 1
  • Novartis Investigative Site 1

Dortmund

  • Gemeinschaftspraxis Dr. med. Josef Leclaire und Dr. med. Thomas Rotermund 1
  • Novartis Investigative Site 1

Eltville

  • Gemeinschaftspraxis für Neurologie und Psychiatrie, Psychotherapie 1
  • Novartis Investigative Site 1

Frankfurt

  • Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie 1
  • Varisano Klinikum Frankfurt Höchst GmbH 1

Gladenbach

  • Neurologie & Psychiatrie Gladenbach - MS-Zentrum 1
  • Novartis Investigative Site 1

Hettingen

  • Haus- und Facharztzentrum Laucherttal / Alb 1
  • Novartis Investigative Site 1

Meerbusch

  • Praxis Dr. Leussink 1
  • Novartis Investigative Site 1

Minden

  • Neurologie am Preußenmuseum 1
  • Novartis Investigative Site 1

Neuruppin

  • Ruppiner Kliniken, Hochschulklinikum der Medizinischen Hochschule Brandenburg, Klinik für Neurologie 1
  • Novartis Investigative Site 1

Osnabrück

  • Neurologie an der Hase 1
  • Novartis Investigative Site 1

Pforzheim

  • Facharztpraxis für Neurologie und Psychiatrie Dres Mattes/Stockert 1
  • Novartis Investigative Site 1

Regensburg

  • Gemeinschaftspraxis für Neurologie 1
  • Novartis Investigative Site 1

Remscheid

  • Gemeinschaftspraxis Dr. Stienker-Fisse & Dr. Fisse 1
  • Novartis Investigative Site 1

Rülzheim

  • ZNS Südpfalz 1
  • Novartis Investigative Site 1

Schwetzingen

  • Neurologische Praxis Dr. Wagner 1
  • Novartis Investigative Site 1

Sinsheim

  • Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim 1
  • Novartis Investigative Site 1

Weil der Stadt

  • Praxis für Neurologie, Psychiatrie und Epileptologie 1
  • Novartis Investigative Site 1

Wolfratshausen

  • Praxis Dr. Michaela Krause 1
  • Novartis Investigative Site 1

Cottbus

  • Novartis Investigative Site 1

Westerstede

  • Studienzentrum Nordwest Dr med Joachim Springub Herr Wolfgang Schwarz 1

Kassel

  • Neurologischen Gemeinschaftspraxis Kassel und Vellmar 1

Meisenheim

  • Local Institution - 0031 1

Bielefeld

  • Neurozentrum Bielefeld 1

Mainz

  • Research Site 1

Mönchengladbach

  • Maria Hilf Clinics 1

Aachen

  • Uniklinik RWTH Aachen 1

Amberg

  • Gesundheitszentrum St. Marien GmbH 1

Arnsdorf

  • Sächsisches Krankenhaus Arnsdorf 1

Aschaffenburg

  • Neuropraxis im Stadtpalais Dres. Ulzheimer/Herröder/Wessig GbR 1

Bad Soden

  • Neurologie Bad Soden 1

Berg

  • Marianne-Strauß-klinik 1

Buchholz

  • Krankenhaus Buchholz Abt. Neurologie 1

Erbach/Odenwald

  • NeuroCentrum Odenwald 1

Forchheim

  • Praxis für Neurologie, Nervenheilkunde & Neurochirurgie 1

Füssen

  • Praxis im Bahnhof 1

Günzburg

  • MVZ Bezirkskliniken Schwaben, Standort Günzburg 1

Hennigsdorf

  • Oberhavel Kliniken GmbH, Klinik Hennigsdorf, Neurologie 1

Herford

  • Praxis Dr. Hospely 1

Isselburg

  • Augustahospital Anholt;Neurologie 1

Kiel

  • Uniklinik Schleswig-Holstein 1

Neu-Ulm

  • Neurologisch-psychiatrische Praxis im A4 1

Neuburg am Inn

  • Praxis Dr. med. Bergmann 1

Öhringen

  • Dres. Beckmann / Schlüter 1

Quakenbrück

  • Neurologisches Studienzentrum Artland 1

Singen

  • EMSA - Zentrum für Neurologie?/?Psychiatrie?/?Neuroradiologie 1

Steglitz

  • Gemeinschaftspraxis Dr. Wolfram von Pannwitz, MBA & Dr. med. Marie Perle Brinckmann 1

Sundern

  • Sauerlandklinik Hachen 1

Zwickau

  • Heinrich-Braun-Krankenhaus Städtisches Klinikum 1

Herne

  • Marienhospital Herne, Klinikum Der Ruhr-Universitaet Bochum 1

Albstadt

  • Novartis Investigative Site 1

Nagold

  • Novartis Investigative Site 1

Schwäbisch Hall

  • Novartis Investigative Site 1

Dillingen an der Donau

  • Novartis Investigative Site 1

Neuburg A.d. Donau

  • Novartis Investigative Site 1

Untermeitingen

  • Novartis Investigative Site 1

Falkensee

  • Novartis Investigative Site 1

Wildeshausen

  • Novartis Investigative Site 1

Gelsenkirchen

  • Novartis Investigative Site 1

Oer-Erkenschwick

  • Novartis Investigative Site 1

Ingelheim

  • Novartis Investigative Site 1

Saarlouis

  • Novartis Investigative Site 1

Görlitz

  • Novartis Investigative Site 1

Altmark

  • Novartis Investigative Site 1

Altenburg

  • Novartis Investigative Site 1

Mühlhausen

  • Novartis Investigative Site 1

Aalen

  • Novartis Investigative Site 1

Altenholz

  • Novartis Investigative Site 1

Alzey

  • Novartis Investigative Site 1

Bayreuth

  • Novartis Investigative Site 1

Bergneustadt

  • Novartis Investigative Site 1

Böblingen

  • Novartis Investigative Site 1

Braunschweig

  • Novartis Investigative Site 1

Coburg

  • Novartis Investigative Site 1

Crailsheim

  • Novartis Investigative Site 1

Dessau

  • Novartis Investigative Site 1

Dillingen Saar

  • Novartis Investigative Site 1

Duisburg

  • Novartis Investigative Site 1

Eisleben Lutherstadt

  • Novartis Investigative Site 1

Fulda

  • Novartis Investigative Site 1

Hagen

  • Novartis Investigative Site 1

Höxter

  • Novartis Investigative Site 1

Kaiserslautern

  • Novartis Investigative Site 1

Karlsruhe

  • Novartis Investigative Site 1

Lünen

  • Novartis Investigative Site 1

Merzig

  • Novartis Investigative Site 1

Mettmann

  • Novartis Investigative Site 1

Montabaur

  • Novartis Investigative Site 1

Mülheim

  • Novartis Investigative Site 1

Oldenburg

  • Novartis Investigative Site 1

Potsdam

  • Novartis Investigative Site 1

Rüdersdorf

  • Novartis Investigative Site 1

Salzatal

  • Novartis Investigative Site 1

Schiltach

  • Novartis Investigative Site 1

Schneverdingen

  • Novartis Investigative Site 1

Stadtroda

  • Novartis Investigative Site 1

Tirschenreuth

  • Novartis Investigative Site 1

Trier

  • Novartis Investigative Site 1

Velbert

  • Novartis Investigative Site 1
🇫🇷France309

Paris

  • Novartis Investigative Site 2
  • 15/20 Hospital 1
  • Pitié Salpetrière Hospital 1
  • Adolphe de Rothschild Hospital 1
  • AP-HP Höpital la Pitié-Salpétrière 1
  • Groupe Hospitalier Universitaire Henri Mondor 1
  • Assistance Publique des Hôpitaux de Paris (APHP)-Hôpital Pitié-Salpêtrière 1
  • Fondation Ophtalmologique Rothschild 1
  • Groupe Hospitalier Pitie-Salpetriere 1
  • Hôpital Cochin 1
  • Hôpital Pitié-Salpêtrière 1
  • Groupe Hospitalier Pitié Salpêtrière - APHP 1
  • CIC Neurosciences, GH Pitié-Salpêtrière 1
  • AP-HP, Hôpital de la Pitié Salpêtrière 1
  • Hôpital TENON 1
  • CIC Neurosciences - Pitié Salpêtrière 1
  • Service de Neurologie, GH Pitié Salpêtrière 1
  • Assistance Publique Hôpitaux de Paris- La Pitié Salpêtrière Hospital 1
  • Hopital Fondation ROTSCHILD 1
  • Paris 1
  • Hopital Fondation Adolphe de Rothschild 1
  • Fondation Ophtalmologique Adolphe de Rothschild (FOR) 1
  • CIC Neurosciences 1
  • Hôpital Paris Saint Joseph 1
  • Fondation Rotschild 1
  • Hôpital national des Quinze-Vingt. 1
  • Hopital Pitie Salpetriere 1
  • Fondation Ophtalmologique Adolphe de Rothschld 1

Lille

  • Novartis Investigative Site 2
  • Hop Claude Huriez Chu Lille 2
  • Roger Salengro Hospital - Lille University Hospital 1
  • Catholics Institut Hospitals Group 1
  • CH St Vincent de Paul 1
  • Hopital Roger Salengro Service de Neurologie 1
  • Groupe Hospitalier de l'Institut Catholique de Lille 1
  • Groupement des Hôpitaux de l'Institut Catholique de Lille Hôpital Saint Vincent de Paul 1
  • CHU de Lille-Hôpital Roger Salengro 1
  • CHRU Lille, Hôpital Claude Huriez, Rue Michel Polonosvski 1
  • Hôpital Roger Salengro 1
  • CHRU 1
  • Saint Vincent hospital 1
  • Lille Hospital 1
  • CHU de Lille 1
  • CHU Lille 1
  • Hôpital St Vincent De Paul 1
  • Chru de Lille 1

Nice

  • Novartis Investigative Site 2
  • CHU de Nice 2
  • Nice University Hospital 2
  • Pasteur Hospital 1
  • Hôpital Pasteur 1
  • CHU de Nice - Hôpital Pasteur 2 1
  • CHU de Nice-Hôpital Pasteur 1
  • Hôpital L'Archet 1
  • University Hospital Pasteur 2 1
  • Nice Hospital 1
  • Hopital Pasteur 1

Rennes

  • Pontchaillou Hospital 1
  • Novartis Investigative Site 1
  • Centre Hospitalier Universitaire de Rennes, Hôpital Pontchaillou 1
  • CHU de Rennes-C.H.R. Pontchaillou 1
  • CHU Rennes - Hopital Pontchaillou 1
  • CHU de Rennes/Pontchaillou 1
  • CHU Rennes 1
  • Pole MPR Saint Hélier 1
  • Centre Eugène Marquis 1
  • Service de Neurologie, CHU Pontchaillou 1
  • CHU de Rennes 1
  • University Hospital Pontchaillou 1
  • Rennes Hospital 1
  • Hopital Pontchaillou 1

Strasbourg

  • Novartis Investigative Site 2
  • Hopital de Hautepierre 1
  • CHRU de Strasbourg - Hôpital Hautpierre 1
  • Les Hôpitaux Universitaires de Strasbourg 1
  • CHU Strasbourg Hpital Hautepierre 1
  • CHRU de Strasbourg 1
  • Hôpital de Hautepierre 1
  • University Hospital of Hautepierre 1
  • Hôpitaux Universitaires de Strasbourg 1
  • Strasbourg Hospital 1
  • Centre d'Investigation Clinique - CHU de Strasbourg - France 1
  • Hopital Hautepierre 1
  • Les Hôpitaux Universitaires 1

Montpellier

  • Hopital Gui de Chauliac 3
  • Gui de Chauliac Hospital - Montpellier University Hospital 1
  • Neurology Department, Hospital Gui de Chauliac 1
  • Novartis Investigative Site 1
  • CHRU de Montpellier - Hôpital Gui de Chauliac 1
  • CHU de Montpellier-Hôpital G. De Chauliac 1
  • CHU de Montpellier - Hôpital Guy de Chauliac 1
  • Neurology Department, Hopital Gui de Chauliac 1
  • Montpellier Hospital 1
  • Hôpital Gui de Chauliac 1
  • CHU de Montpellier - CIMA 1

Bordeaux

  • Groupe Hospitalier Pellegrin 2
  • CHU de Bordeaux - service de neurologie 2
  • Pellegrin Hospital Group 1
  • Novartis Investigative Site 1
  • CHU de Bordeaux-Hôpital Pellegrin 1
  • Centre Hospitalier Universitaire de Bordeaux, Service de Rhumatologie 1
  • CHU de Bordeaux 1
  • Bordeaux Hospital 1
  • Hopital Pellegrin 1

Clermont-Ferrand

  • Novartis Investigative Site 2
  • Gabriel Montpied Hospital 1
  • Hopital Gabriel Montpied CHU de Clermont-Ferrand 1
  • Hôpital Gabriel Montpieds 1
  • CHU de Clermont-Ferrand-Hôpital Gabriel Montpied 1
  • CHU Hopital Gabriel Montpied 1
  • CHU de Clermont-Ferrand - Service de Neurologie 1
  • CHU de Clermont-Ferrand 1
  • Clermont-Ferrand Hospital 1
  • Hopital Gabriel Montpied 1

Nîmes

  • Novartis Investigative Site 2
  • CHU de Nîmes 2
  • Hopital Caremeau 2
  • Nimes University Hospital 1
  • Centre Hospitalier Universitaire de Nimes (CHU) - Hopital Universitaire Caremeau 1
  • GroupeHospitalo-Universitaire Caremeau 1
  • CHU de Nîmes - Hôpital Caremeau 1
  • Nimes Hospital 1

Toulouse

  • Novartis Investigative Site 2
  • Hopital Purpan 2
  • Toulouse Hospital 2
  • Purpan Hospital 1
  • CHU de Toulouse - Bâtiment Pierre Paul Riquet 1
  • CHU Toulouse - Département de Neurologie 1
  • CHU Toulouse - Service de médecine nucléaire 1

Nancy

  • Novartis Investigative Site 1
  • Centre Hospitalier Régional de Nancy 1
  • CHU de Nancy -Hôpital Central 1
  • CHU Nancy Hôpital Central 1
  • CHU Nancy 1
  • CHU de Nancy 1
  • Nancy Hospital 1
  • Centre Hospitalier Régional Universitaire 1
  • Hôpital Central 1
  • CIC 1433 Épidémiologie clinique, Inserm, Université de Lorraine, CHRU de Nancy 1

Lyon

  • Lyon Civil Hospices 1
  • Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer 1
  • Centre Médical Germaine REVEL 1
  • Département de Neurologie,Pierre Wertheimer Neurological Hospital 1
  • CERMEP 1
  • Hospices civils de Lyon 1
  • Cabinet médical Dr Philippe NEUSCHWANDER 1
  • Centre Hospitalier Saint Joseph Saint Luc 1
  • Cabinet médical Dr C. CORNUT-CHAUVINC 1

Nantes

  • Nantes University Hospital 2
  • Laennec Hospital 1
  • Novartis Investigative Site 1
  • Hopital Nord Laennec 1
  • CHU de Nantes -Hôpital Nord Laennec 1
  • University Hospital 1
  • CHU de Nantes 1
  • University Hospital Laennec 1

Marseille

  • Novartis Investigative Site 1
  • AP-HM - Hôpital la Timone 1
  • Assistance Publique des Hôpitaux de Marseille (APHM)-Hôpital La Timone Adultes 1
  • Assistance Publique Hopitaux de Marseille 1
  • Assistance Publique Des Hotipaux de Marseille 1
  • Marseille Hospital / La Timone 1
  • Chu Timone 1
  • Hopital Timone Adultes 1

Rouen

  • Charles Nicolle Hospital 2
  • Novartis Investigative Site 1
  • CHU de Rouen - Hôpital Charles Nicolle 1
  • CHU de Rouen-Hôpital Charles Nicolle 1
  • Rouen Hospital 1
  • Hôpital Charles-Nicolle 1

Caen

  • Côte de Nacre University Hospital 1
  • CHU De Caen 1
  • Centre Hospitalier Universitaire de Caen 1
  • CHU de Caen-Hôpital Côte de Nacre 1
  • Caen Hospital 1
  • Hopital Cote de Nacre 1

Créteil

  • GCS CHIC Henri Mondor 1
  • Assistance Publique des Hôpitaux de Paris (APHP)-Hôpital Henri Mondor 1
  • APHP Henri Mondor 1
  • CHU Henri Mondor 1
  • Hôpital Henri Mondor 1
  • Hopital Henri Mondor 1

Dijon

  • Dijon Hospital University 1
  • CHU de Dijon-Hôpital du Bocage 1
  • CHU Dijon 1
  • CHU de Dijon Bourgogne 1
  • Dijon Hospital 1
  • Hopital Du Bocage 1

Poitiers

  • Novartis Investigative Site 2
  • La Miletrie University Hospital 1
  • PoitiersUH 1
  • Poitiers Hospital 1
  • Chr La Miletrie 1

Tours

  • Novartis Investigative Site 2
  • Tours Hospital University 1
  • CHU de Tours 1
  • tours Hospital 1
  • Chru de Tours Hopital Bretonneau 1

Grenoble

  • Nord Hospital - Grenoble University Hospital 1
  • Novartis Investigative Site 1
  • CHU Grenoble Alpes 1
  • Grenoble Alpes Hospital 1
  • Chu de Grenoble 1

Poissy

  • Intercommunal Hospital Center of Poissy Saint-Germain 1
  • Centre Hospitalier Intercommunal de Poissy 1
  • Hôpital Saint-Germain 1
  • CHIC Poissy 1
  • Chi Poissy Saint Germain En Laye 1

Bron

  • Hopital neurologique Pierre Wertheimer - CHU Lyon 1
  • Hopital Neurologique Pierre Wertheimer 1
  • Hôpital Neurologique Pierre WERTHEIMER - HCL 1
  • Hospice Civil de Lyon - Hospital Pierre Wertheimer 1
  • Hôpital Neurologique Pierre Wertheimer 1

Gonesse

  • France 2
  • Centre hospitalier de Gonnesse 1
  • CH de Gonesse 1
  • Centre hospitalier Joséphine Baker Gonesse 1

Besançon

  • Jean Minjoz University Hospital 1
  • CHU de Besancon Hopital Jean Minjoz 1
  • CHU de Besançon 1
  • Hopital Jean Minjoz 1

Limoges

  • Novartis Investigative Site 1
  • Centre Hospitalier Universitaire de Limoges 1
  • CHU de Limoges-Hôpital Dupuytren 1
  • Hopital Dupuytren 1

Brest

  • CHU Brest Hopital La Cavale Blanche 1
  • CHRU de Brest - Hôpital la Cavale Blanche 1
  • CHU Brest 1

Saint-Herblain

  • CHU Nantes -CIC de Neurologie 1
  • CHU Nantes - Hopital Nord Laënnec 1
  • Hopital G. Et R. Laennec 1

Amiens

  • Novartis Investigative Site 1
  • Chu D'Amiens 1

Suresnes

  • Hôpital Foch 2

La Tronche

  • CHU de Grenoble Alpes 1
  • CHU Grenoble Alpes 1

Garches

  • Hôpital Raymond-Poincaré 1
  • Hôpital Raymond Poincaré 1

Lomme

  • Hopital Saint Philibert 1
  • Saint-Philibert hospital 1

Colmar

  • Hospices Civils de Colmar 1
  • CHU Colmar 1

Metz

  • Chr Metz-Thionville 1
  • CHR Metz-Thionville / Mercy Hospital 1

Épinal

  • Hôpital Emile Durkheim Epinal 1
  • Ch Epinal 1

Libourne

  • Libourne Hospital Center 1

Ajaccio

  • Novartis Investigative Site 1

Orsay

  • Novartis Investigative Site 1

Amiens Cedex1

  • CHU Amiens Hopital Sud 1

Bayonne

  • CHIC Cote Basque Bayonne 1

Cergy-Pontoise

  • Centre Hospitalier de Pontoise - GHT NOVO 1

Quimper

  • Centre Hospitalier de Cornouaille 1

Berck

  • Centre Jacques Calvé Fondation Hopale 1

Gaillac-Toulza

  • Clinique Verdaich 1

Saint-Genis-Laval

  • Hôpital Henry Gabrielle 1

Hérouville-Saint-Clair

  • IMPR du Bois de Lébisey 1

La Membrolle-sur-Choisille

  • CMPR Bel-Air 1

Le Kremlin-Bicêtre

  • Service de Neurologie Pédiatrique, Hôpital du Kremlin Bicêtre 1

Arras

  • CH Arras 1

Lens

  • CH LENS 1

Haguenau

  • Centre Hospitalier de Haguenau 1

Mulhouse

  • Grpe Hosp Region Mulhouse & Sud Alsace 1

Reims

  • Chu Reims 1

Angers

  • Angers Hospital 1

Antibes

  • Antibes Hospital 1

La Roche-sur-Yon

  • CHD Vendee 1

Saint-Brieuc

  • Saint-Brieuc Hospital 1

St-Malo

  • Groupement Hospitalier Rance Emeraude Saint Malo 1

Vannes

  • Groupement Hospitalier Brocéliande Atlantique Vannes 1

Héricourt

  • Centre de Médecine Physique et de Réadaptation Bretegnier 1

Ars-Laquenexy

  • Centre Hospitalier Régional de Metz, site Mercy 1

Annecy

  • Centre Hospitalier Annecy Genevois 1

Avignon

  • Centre Hospitalier d'Avignon 1

Brive-la-Gaillarde

  • Hôpital de Brive 1

Chambéry

  • Centre hospitalier Métropole Savoie 1

Le Chesnay

  • Centre Hospitalier de Versailles Hôpital Andre Mignot 1

Mornant

  • Cabinet médical Dr L. GUILLOTON 1

Pontoise

  • Hopital Rene Dubos 1

Saint-Denis

  • Centre Hospitalier de Saint-Denis 1

Saint-Lô

  • Centre Hospitalier Mémorial 1

Saint-Priest-en-Jarez

  • Hopital Nord 1

Villeurbanne

  • Médipôle Lyon Villeurbanne 1
🇵🇱Poland124

Warsaw

  • Centrum Medyczne NeuroProtect 3
  • TG Therapeutics Investigational Trial Site 3
  • MTZ Clinical Researcz Powered by pratia 2
  • Children's Memorial Health Institute, Neurology and Epileptology 2
  • Institute of Psychiatry and Neurology 2
  • Novartis Investigative Site 1
  • Medical University of Warsaw, Department of Pediatric Neurology 1
  • Centrum Medyczne NeuroProtect (NeuroProtect Medical Center) 1
  • City Clinic Research 1
  • Instytut "Pomnik - Centrum Zdrowia Dziecka" 1
  • MTZ Clinical Research powered by Pratia 1

Katowice

  • Centrum Medyczne Pratia Katowice 2
  • NZOZ Novo Med 2
  • Neuro Medic Clinic 2
  • TG Therapeutics Investigational Trial Site 2
  • MA-LEK Clinical Sp. z o.o. 1
  • Novartis Investigative Site 1
  • Centrum Medyczne Pratia Katowice I 1
  • NEURO-CARE Sp. z o.o. Sp. Komandytowa 1
  • M.A. LEK A.M.Maciejowscy SC. 1
  • Local Institution - 0079 1
  • M.A. - LEK A.M. Maciejowscy S.C., Centrum Terapii SM 1

Poznan

  • TG Therapeutics Investigational Trial Site 3
  • Twoja Przychodnia PCM 2
  • Nzoz Neuro-Kard Ilkowski I Partnerzy Spolka Partnerska Lekarzy 2
  • Prywatna Lecznica Certus Sp. z o.o. 1
  • Local Institution - 0108 1
  • CT-P53 3.1 investigational site 1
  • NZOZ NEURO-KARD Ilkowski i Partnerzy Sp. Partn. Lek 1
  • Uniwersytecki Szpital Kliniczny w Poznaniu 1

Krakow

  • TG Therapeutics Investigational Trial Site 2
  • SP ZOZ Szpital Uniwersytecki w Krakowie 2
  • Novartis Investigative Site 1
  • Samodzielny Publiczny Zakad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie 1
  • Szpital Specjalistyczny im. L. Rydygiera w Krakowie 1
  • Michalski i Partnerzy Lekarze Spółka Partnerska 1
  • Pratia MCM Krakow 1
  • Szpital Uniwersytecki w Krakowie, Oddzial Kliniczny Neurologii 1
  • Jagiellonian University Medical College, Department of Neurology 1

Lublin

  • Malva Trials 2
  • Galen Clinic 2
  • NZOZ Neuromed M. i M. Nastaj Sp.P 2
  • Instytut Naukowo-Badawczy w Lublinie Sp. z o.o. 1
  • Novartis Investigative Site 1
  • Indywidualna Praktyka Lekarska Prof. Dr Hab. N. Med. Konrad Rejdak. 1
  • Zanamed Medical Clinic sp z o o 1

Bydgoszcz

  • Centrum Medyczne INTERCOR Sp. z o.o. 2
  • TG Therapeutics Investigational Trial Site 2
  • Novartis Investigative Site 1
  • Neurocentrum Bydgoszcz sp z o.o 1
  • Centrum Medyczne NEUROMED 1
  • Local Institution - 0044 1

Lodz

  • TG Therapeutics Investigational Trial Site 2
  • Centrum Neurologii Krzysztof Selmaj 1
  • PRO SALUS Sp. z o.o. sp.k. 1
  • Novartis Investigative Site 1
  • Medical University of Lodz 1
  • Local Institution - 0076 1

Zabrze

  • TG Therapeutics Investigational Trial Site 2
  • ClinHouse Centrum Medyczne 1
  • Novartis Investigative Site 1
  • Samodzielny Publiczny Szpital Kliniczny Nr 1 im. Prof. Stanislawa SzyszkoSUM w Katowicach 1
  • Medical University of Silesia 1

Rzeszów

  • Nmedis sp.z o.o. 1
  • Nmedis sp. z o.o. 1
  • Novartis Investigative Site 1
  • TG Therapeutics Investigational Trial Site 1
  • Centrum Medyczne Medyk 1

Gdansk

  • Copernicus Podmiot Leczniczy Szpital im. M. Kopernika 1
  • TG Therapeutics Investigational Trial Site 1
  • Uniwersyteckie Centrum Kliniczne 1
  • Local Institution - 0061 1

Żory

  • Centrum Medyczne ProNeuro Żory 2
  • Novartis Investigative Site 1
  • TG Therapeutics Investigational Trial Site 1

Szczecin

  • Euromedis Osrodek Badan Klinicznych 1
  • EUROMEDIS Osrodek Badan Klinicznych 1
  • Novartis Investigative Site 1

Kielce

  • TG Therapeutics Investigational Trial Site 2
  • Resmedica NZOZ Kielce 1

Nowa Sól

  • Twoja Przychodnia Centrum Medyczne Nowa Sol 1
  • Twoja Przychodnia Centrum Medyczne Nowa Sól 1

Olsztyn

  • TG Therapeutics Investigational Trial Site 2

Plewiska

  • Neurologiczny Niepubliczny ZOZ Centrum Leczenia SM Osrodek Badan Klinicznych im. dr n. med. Hanki Hertmanowskiej 1

Chojnice

  • Novartis Investigative Site 1

Skorzewo

  • Novartis Investigative Site 1

Rzeszw

  • Nmedis sp. z o.o. 1

?ory

  • ProNeuro Centrum Medyczne 1

?ód?

  • SOMED - Lodzkie Centrum Osteoporozy 1

Gda?sk

  • COPERNICUS Podmiot Leczniczy Sp z o o 1

Wroc?aw

  • Penta Hospitals Przychodnie, Wroclaw Wejherowska 1

Oświęcim

  • Instytut Zdrowia Dr Boczarska Jedynak 1

Słomniki

  • Local Institution - 0051 1
🇪🇸Spain112

Madrid

  • Hospital Universitario Ramon y Cajal 3
  • Hospital Gregorio Marañon 2
  • Novartis Investigative Site 2
  • Hospital Universitario 12 de Octubre 1
  • Investigational Site Number : 7240023 1
  • Hospital Ruber Internacional 1
  • Hospital Universitario de la Princesa 1
  • Hospital General Universitario Gregorio Maranon 1
  • Hospital Clinico San Carlos 1
  • Hospital Universitario Ramon Y Cajal 1
  • Hospital Universitario de La Princesa 1
  • Research Site 1
  • Fundación Esclerosis Multiple Madrid (FEMM) 1
  • Escuela Universitaria de Enfermería y Fisioterapia San Juan de Dios - Universidad Pontificia Comillas 1
  • Hospital Universitario San Rafael 1

Barcelona

  • Hospital del Mar 3
  • Novartis Investigative Site 2
  • Investigational Site Number : 7240010 1
  • Hospital Universitari Vall d Hebron 1
  • Hospital Clinic de Barcelona 1
  • Hospital de la Santa Creu i Sant Pau 1
  • Barcelona Sea Hospital (Hospital Del Mar De Barcelona) 1
  • Hospital Universitario Vall D Hebron 1
  • Research Site 1
  • Hospital Universitario Vall d'Hebron - PPDS 1
  • Centre d'Esclerosi Mútiple de Catalunya (Cemcat) 1
  • Hospital del Mar Research Institute 1

Seville

  • Hospital Universitario Virgen Macarena 3
  • Novartis Investigative Site 2
  • Hospital Universitario Virgen Del Rocio 1
  • Hopsital Universitario Virgen Macarena 1

Málaga

  • Novartis Investigative Site 2
  • Vithas Hospital Parque San Antonio 1
  • Investigational Site Number : 7240005 1
  • Hospital Regional Universitario de Malaga 1
  • Hospital Regional Universitario De Malaga 1

Valencia

  • Hospital Universitari i Politecnic La Fe 3
  • Novartis Investigative Site 2
  • Hospital Universitari i Politecnic La Fe de Valencia 1

Vigo

  • Hospital Alvaro Cunqueiro 3
  • Investigational Site Number : 7240014 1
  • CHUVI- Hospital Alvaro Cunqueiro 1

Castilleja de la Cuesta

  • Hospital Vithas Nisa Sevilla 2
  • Novartis Investigative Site 1

Pozuelo de Alarcón

  • Investigational Site Number : 7240001 1
  • Novartis Investigative Site 1
  • Hospital Universitario Quironsalud Madrid 1

L'Hospitalet de Llobregat

  • Novartis Investigative Site 1
  • Hospital Universitari de Bellvitge 1
  • Hospital Universitario de Bellvitge 1

El Palmar

  • Novartis Investigative Site 2
  • Hospital Universitario Virgen de La Arrixaca 1

Toledo

  • Asociación de Esclerosis Múltiple de Toledo 1
  • Universidad de Castilla La Mancha 1
  • University of Castilla La Macha 1

Majadahonda

  • Hospital Universitario Puerta de Hierro de Majadahonda 2

A Coruña

  • Complejo Hospitalario Universitario A Coruna 1
  • Complejo Hospitalario Universitario A Coruña 1

Albacete

  • Novartis Investigative Site 1
  • Complejo Hospitalario Universitario de Albacete 1

Barakaldo

  • Novartis Investigative Site 1
  • Hospital de Cruces 1

Alicante

  • Novartis Investigative Site 1
  • Hospital General Universitario Dr. Balmis de Alicante 1

Lleida

  • Novartis Investigative Site 1
  • Hospital Universitari Arnau de Vilanova 1

Leganés

  • Asociación de Leganés de Esclerosis Múltiple 2

León

  • Hospital Universitario de Ponferrada El Bierzo 1
  • University of Leon 1

Jerez de la Frontera

  • Novartis Investigative Site 1

Logroño

  • Novartis Investigative Site 1

Torrejón de Ardoz

  • Novartis Investigative Site 1

Las Palmas GC

  • Novartis Investigative Site 1

Salamanca

  • Novartis Investigative Site 1

Córdoba

  • Novartis Investigative Site 1

Esplugues de Llobregat

  • Local Institution - 0096 1

Zaragoza

  • Hospital Universitario Miguel Servet 1

Salt

  • Hospital Santa Caterina 1

Santiago de Compostela

  • Complejo Hospitalario Universitario de Santiago. 1

Badalona

  • Germans Trias i Pujol Hospital (HUGTiP) 1

Pontevedra

  • University of Vigo 1

Móstoles

  • Asociación Mostoleña de Esclerosis Múltiple (AMDEM) 1

Villaviciosa de Odón

  • Universidad Europea de Madrid 1
🇮🇹Italy111

Milan

  • IRCCS San Raffaele 3
  • Ospedale San Raffaele 2
  • Investigational Site Number : 3800016 1
  • Novartis Investigative Site 1
  • Local Institution - 0081 1
  • Fondazione IRCCS Istituto Neurologico Carlo Besta 1
  • Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda) 1
  • Istituto Neurologico "Carlo Besta" 1
  • Fondazione Don Carlo Gnocchi Onlus, IRCCS 1
  • IRCCS Fondazione Don Carlo Gnocchi ONLUS 1
  • Istituti a Carattere Scientifico Maugeri Milano Camaldoli 1
  • IRCCS "Santa Maria Nascente" - Fondazione Don Gnocchi 1
  • IRCCS Ospedale San Raffaele 1
  • IRCCS Ospedale San Raffaele - Neurology and Neurophysiology Unit 1
  • IRCCS Santa Maria Nascente - Fondazione Don Carlo Gnocchi 1
  • Università degli Studi di Milano 1
  • IRCCS Istituto Auxologico Italiano 1
  • IRCCS Istituto Neurologico Carlo Besta 1
  • Don Gnocchi Foundation 1

Naples

  • Az. Osp.Universitaria Policlinico Federico II Centro Sclerosi Multipla Dip. Scienze Neurologiche 1
  • Novartis Investigative Site 1
  • University of Naples Federico II 1
  • Azienda Ospedaliera Universitaria Federico II 1
  • Azienda Ospedaliera Universitaria- Universit degli Studi della Campania Luigi Vanvitelli 1
  • Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II 1
  • Centro di Sclerosi Multipla dell'Azienda Ospedaliera Universitaria Federico II 1

Roma

  • Novartis Investigative Site 2
  • Fondazione Policlinico Universitario Campus Bio-Medico Site Number : 3800038 1
  • Azienda Ospedaliera San Camillo Forlanini Site Number : 3800001 1
  • Azienda Ospedaliera Universitaria Policlinico Tor Vergata 1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1
  • Fondazione Policlinico Universitario A. Gemelli IRCCS 1

Pavia

  • Novartis Investigative Site 2
  • Fondazione Istituto Neurologico Nazionale Casimiro Mondino 1
  • Istituto Neurologico Nazionale IRCCS Casimiro Mondino 1
  • U.O.Sclerosi Multipla 1
  • Istituti Clinici Scientifici Maugeri IRCCS 1
  • Istituti a Carattere Scientifico Maugeri Pavia 1

Genova

  • Novartis Investigative Site 1
  • IRCCS Azienda Ospedaliera Universitaria San Martino 1
  • Azienda Sanitaria Genovese 1
  • Ospedale Policlinico San Martino - IRCCS 1
  • Italian multiple sclerosis foundation 1
  • Fondazione Italiana Sclerosi Multipla 1
  • Università di Genova 1

Pozzilli

  • IRCCS Istituto Neurologico Mediterraneo Neuromed 2
  • Novartis Investigative Site 1
  • IRCCS Neuromed 1

Chieti

  • University G. D'Annunzio of Chieti-Pescara 2
  • Novartis Investigative Site 1
  • Fondazione Università G. D'Annunzio 1

Rome

  • Neurological Center Of Latium 1
  • Center for Experimental Neurological Therapies (CENTERS), S. Andrea Hospital, Faculty of Medicine and Psychology, "Sapienza" University of Rome 1
  • IRCCS Fondazione Santa Lucia 1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1

Verona

  • Sezione medicina fisica e riabilitativa dipartimento di neuroscienze 1
  • Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione 1
  • Policlinico GB Rossi - University Hospital Borgo Roma 1
  • University of Verona 1

Cagliari

  • Investigational Site Number : 3801007 1
  • University of Cagliari 1
  • Laboratorio di Biomeccanica ed Ergonomia industriale Università degli Studi di Cagliari 1

Foggia

  • Novartis Investigative Site 2
  • Azienda Ospedaliero-Universitaria Ospedali Riuniti di Foggia Site Number : 3800019 1

Messina

  • IRCCS Centro Neurolesi Bonino-Pulejo 2
  • IRCCS Centro Neurolesi Bonino Pulejo 1

Bergamo

  • Novartis Investigative Site 2

Genoa

  • IRCCS AOM Azienda Ospedaliera Metropolitana 1
  • Servizio di Riabilitazione AISM Liguria, Italian Multiple Sclerosis Society 1

Bologna

  • IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of Bologna 1
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna 1

Ferrara

  • Ferrara University Hospital 2

Bari

  • Istituti Clinici Scientifici Maugeri SpA 1
  • Istituti a Carattere Scientifico Maugeri Bari 1

Brescia

  • IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli 2

Telese Terme

  • ICS Maugeri - IRCCS of Telese Terme 1
  • Istituti a Carattere Scientifico Maugeri Telese 1

Catania

  • Arianna Di Stadio 2

Palermo

  • ARNAS Ospedali Civico Di Cristina 1

Orbassano

  • Universita degli Studi di Torino - Azienda Ospedaliero-Universitaria San Luigi Gonzaga - Clinica di Malattie dell'Apparato Respiratorio Neurologia & CRESM 1

Montichiari

  • Investigational Site Number : 3800037 1

Rozzano

  • Investigational Site Number : 3800036 1

Ancona

  • Novartis Investigative Site 1

Gallarate

  • Novartis Investigative Site 1

Salerno

  • Az. Osp. OO.RR. S. Giovanni di Dio e Ruggi D' Aragona 1

Torino

  • AOU Città della Salute e della Scienza di Torino 1

Lecco

  • Centro Riabilitativo Villa Beretta 1

Modena

  • University of Modena and Reggio Emilia 1

Costa Masnaga

  • Centro di Riabilitazione Villa Beretta 1

Montescano

  • Istituti a Carattere Scientifico Maugeri Montescano 1

Pisa

  • Università di Pisa 1

Cassino

  • San Raffaele Cassino 1

Venice-Lido

  • IRCCS San Camillo 1

Venice

  • Università Ca' Foscari Venezia 1
🇨🇦Canada87

Montreal

  • Novartis Investigative Site 3
  • Montreal Neurological Institute and Hospital 3
  • CRCHUM 1
  • Centre Intégré Universitaire de Sante et Services Sociaux de L'Est de I'lle de Montreal / installation Hopital Maisonneuve-Rosemont 1
  • Jewish General Hospital 1
  • Research Site 1
  • McGill University Health Centre - Centre for Innovative Medicine 1
  • McGill University 1
  • The Neuro 1
  • Genge Partners, Inc. 1
  • Centre Hospitalier de l'Université de Montréal 1
  • Sainte-Justine Université de Montréal 1

Calgary

  • University of Calgary 4
  • Novartis Investigative Site 2
  • Foothills Medical Centre 2
  • University of Calgary Foothills Medical Center 1
  • Alberta Children's Hospital - University of Calgary 1
  • Heritage Medical Research Clinic 1

Toronto

  • Sunnybrook Research Institute 2
  • Unity Health Toronto, St. Michael's Hospital 1
  • Holland Bloorview Kids Rehabilitation Hospital 1
  • The Hospital for Sick Children 1
  • University Health Network-Princess Margaret Hospital 1
  • Toronto Rehabilitation Institute-Lyndhurst Center 1
  • Mount Sinai Health System 1
  • MS Barlo Centre, St Michael's Hospital 1
  • Unity Health Toronto 1
  • St. Michael's Hospital 1

Edmonton

  • Novartis Investigative Site 3
  • University Of Alberta Hospital 1
  • University of Alberta-Glenrose 1
  • University of Alberta Hospital, Edmonton, Division of Neurology 1
  • Walter Mackenzie Health Sciences Centre 1

London

  • London Health Sciences Centre 3
  • University Hospital - London Health Sciences Centre 2
  • University of Western Ontario, Lawson Health Research Institute 1
  • Saint Joseph Health Care Centre 1

Ottawa

  • Novartis Investigative Site 2
  • The Ottawa Hospital - General Campus 2
  • The Ottawa Hospital 1

Halifax

  • Novartis Investigative Site 2
  • Dalhousie University - IWK Health Centre 1
  • Dalhousie University 1

Vancouver

  • Novartis Investigative Site 3

Québec

  • Novartis Investigative Site 2
  • CIRRIS 1

Sherbrooke

  • Novartis Investigative Site 2
  • Centre Hospitalier Universitaire de Sherbrooke (CHUS) 1

Lévis

  • Novartis Investigative Site 2
  • Centre de Recherche Saint-Louis 1

Hamilton

  • McMaster University 3

Burnaby

  • Novartis Investigative Site 2

St. John's

  • Novartis Investigative Site 1

Kingston

  • Queen's University 1

Gatineau

  • Clinique Neuro-Outaouais 1
🇬🇧United Kingdom80

London

  • Royal London Hospital 3
  • King's College Hospital NHS Foundation Trust 3
  • Novartis Investigative Site 2
  • Research Site 2
  • St George's University Hospitals NHS Foundation Trust 1
  • Charing Cross Hospital 1
  • Cambridge Clinical Research Centre 1
  • East Kent Hospitals University NHS Foundation Trust 1
  • St George's Hospital 1
  • The National Hospital for Neurology & Neurosurgery 1
  • Royal London Hospital, Barts Health NHS Foundation Trust 1
  • Barts Health NHS Trust 1
  • Imperial College Healthcare NHS Trust 1
  • University College London Hospitals NHS Foundation Trust 1
  • TG Therapeutics Investigational Trial Site 1
  • Moorfields Eye Hospital NHS Foundation Trust 1
  • Guy's and St Thomas' NHS Foundation Trust 1

Sheffield

  • Sheffield Teaching Hospitals NHS Foundation Trust 2
  • Novartis Investigative Site 1
  • Sheffield Teaching Hospital NHS foundation Trust, Herries Road 1
  • Royal Hallamshire Hospital 1

Edinburgh

  • Anne Rowling Regenerative Neurology Clinic 1
  • Anne Rowling Regenerative Neurology Clinic, University of Edinburgh 1
  • Research Site 1
  • Western General Hospital Edinburgh - PPDSE Edinburgh 1
  • NHS Lothian 1

Glasgow

  • Novartis Investigative Site 1
  • Queen Elizabeth University Hospital Clinical Research Facility 1
  • Queen Elizabeth University Hospital 1
  • NHS Greater Glasgow & Clyde - Institute of Neurological Sciences 1

Bristol

  • Novartis Investigative Site 1
  • North Bristol NHS Trust - Southmead Hospital 1
  • Zoe Plummer 1

Leeds

  • Novartis Investigative Site 2
  • Leeds Teaching Hospitals NHS Trust 1

Nottingham

  • Novartis Investigative Site 1
  • University of Nottingham 1
  • Nottingham University NHS Trust 1

Swansea

  • Novartis Investigative Site 1
  • Morriston Hospital 1
  • FHMLS, Nutrition Lab 1

Birmingham

  • University Hospitals of Birmingham NHS Foundation Trust 1
  • Birmingham Children's Hospital 1
  • Aston University 1

Cambridge

  • Cambridge University Hospitals NHS Foundation Trust 1
  • Research Site 1
  • Addenbrooke's Hospital 1

Cardiff

  • Cardiff and Vale University Local Health Board 1
  • University Hospital of Wales 1
  • Cardiff and Vale University Health Board - University Hospital Wales 1

Salford

  • Clinical Research Facility Salford Royal NHS Foundation Trust 1
  • Salford Care Organisation 1
  • Salford Care Organization 1

Brighton

  • Novartis Investigative Site 1
  • University Hospitals Sussex NHS Foundation Trust 1

Newcastle upon Tyne

  • Newcastle upon Tyne Hospitals NHS Foundation Trust 1
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust 1

Oxford

  • Oxford Centre for Enablement (OUH NHS-FT) 1

Romford

  • Novartis Investigative Site 1

Coventry

  • Novartis Investigative Site 1

Stoke-on-Trent

  • Novartis Investigative Site 1

Portadown

  • Southern Health and Social Care Trust, Craigavon Area Hospital 1

Aberdeen

  • Aberdeen Royal Infirmary 1

Bury St Edmunds

  • West Suffolk NHS Foundation Trust 1

Dundee

  • Clinical Research Centre , Ninewells Hospital 1

Exeter

  • Royal Devon and Exeter Hospital 1

Inverness

  • NHS Highland Clinical Research Facility, Raigmore Hospital 1

Ipswich

  • East Suffolk and North Essex NHS Foundation Trust 1

Norwich

  • Norfolk and Norwich University Hospitals NHS Foundation Trust 1

Poole

  • University Hospitals of Dorset NHS Trust 1

Southampton

  • Clinical Research Facility University Hospital Southampton 1

Truro

  • Royal Cornwall Hospital 1
🇦🇺Australia60

Melbourne

  • Neurology Network 1
  • Novartis Investigative Site 1
  • Royal Children's Hospital 1
  • The Alfred 1
  • Research Site 1
  • Austin Health 1
  • Australian MND Registry 1
  • FightMND 1
  • Institute for Breathing and Sleep 1
  • Monash University 1
  • University of Melbourne 1
  • Royal Melbourne Hospital 1

Sydney

  • Macquarie University 2
  • University of Sydney - Brain and Mind Research Institute (BMRI) 1
  • Concord Repatriation General Hospital 1
  • Royal Prince Alfred Hospital 1
  • Westmead Hospital 1

Heidelberg

  • Austin Health 2
  • Austin Hospital 2
  • Novartis Investigative Site 1

Adelaide

  • CMAX Clinical Research 1
  • CMAX 1
  • SOCRU 1
  • Flinders Medical Centre 1

Kogarah

  • Southern Neurology Suite 2 1
  • Novartis Investigative Site 1
  • Southern Neurology 1

New Lambton Heights

  • Novartis Investigative Site 1
  • John Hunter Hospital 1

Westmead

  • Novartis Investigative Site 1
  • Corner Hawkesbury Road and Darcy Road 1

Parkville

  • Novartis Investigative Site 1
  • The Royal Melbourne Hospital 1

Liverpool

  • Novartis Investigative Site 1
  • Research Site 1

Box Hill

  • Box Hill Hospital 2

Birtinya

  • University of the Sunshine Coast Clinical Trials 1
  • Sunshine Coast University Hospital 1

Waratah

  • Research Site 2

Clayton

  • Novartis Investigative Site 1

Murdoch

  • Novartis Investigative Site 1

Southport

  • Novartis Investigative Site 1

St Leonards

  • Novartis Investigative Site 1

Camperdown

  • Brain and Mind Centre 1

Newcastle

  • John Hunter Hospital 1

Kent Town

  • Centre for Neuroscience Innovation 1

Hobart

  • Menzies Research Institute 1

Nedlands

  • Perron Institute 1

Darlinghurst

  • Research Site 1

Concord

  • Concord Repatriation General Hospital 1

Herston

  • Nucleus Network 1

Brisbane

  • The Prince Charles Hospital 1

Canberra

  • Motor Neurone Disease Australia 1

Perth

  • Sir Charles Gairdner Hospital 1
🇨🇳China60

Wuhan

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology 5
  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology 2
  • Novartis Investigative Site 1
  • Tongji Hospital, Tongji Medical College of Hust 1
  • Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology 1
  • Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology 1

Beijing

  • Xuanwu Hospital, Capital Medical University 4
  • Investigational Site Number : 1560005 1
  • Novartis Investigative Site 1
  • Beijing Tiantan Hospital, Capital Medical University 1
  • Department of Rheumatology and Immunology, Peking University People's Hospital 1
  • Beijing GoBroad Hospital 1
  • Beijing Tiantan Hospital 1

Guangzhou

  • Investigational Site Number : 1560002 1
  • Novartis Investigative Site 1
  • The Third Affiliated Hospital, Sun Yat-sen University 1
  • Sun Yat-sen Memorial Hospital 1
  • The Third Affiliated Hospital of Sun Yat-sen University 1

Hangzhou

  • Children's Hospital, Zhejiang University School of Medicine 4
  • Novartis Investigative Site 1

Tianjin

  • Tianjin Huanhu Hospital 2
  • Novartis Investigative Site 1

Chengdu

  • Investigational Site Number : 1560004 1
  • Investigational Site Number : 1561029 1

Shenyang

  • Investigational Site Number : 1560014 1
  • Novartis Investigative Site 1

Zhengzhou

  • Novartis Investigative Site 1
  • The First Affiliated Hospital of Zhengzhou University 1

Shanghai

  • Novartis Investigative Site 1
  • Department of Rheumatology, RenJi Hospital, School of Medicine, Shanghai JiaoTong University 1

Dongguan

  • Investigational Site Number : 1560020 1

Jiazhuang

  • Investigational Site Number : 1560010 1

Zunyi

  • Novartis Investigative Site 1

Hohhot

  • Novartis Investigative Site 1

Suzhou

  • Novartis Investigative Site 1

Changchun

  • Novartis Investigative Site 1

Yinchuan

  • Novartis Investigative Site 1

Xianyang

  • Novartis Investigative Site 1

Taiyuan

  • Novartis Investigative Site 1

Wenzhou

  • Novartis Investigative Site 1

Chongqing

  • Novartis Investigative Site 1

Xi'an

  • Xijing Hospital 1

Qingdao

  • The Affiliated Hospital of Qingdao University 1

Hubei

  • Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science & Technology 1

Nanjing

  • Nanjing Children's Hospital 1
🇹🇷Turkey (Türkiye)57

Istanbul

  • Biruni University 2
  • Istanbul University Istanbul Medical Faculty 1
  • Istanbul University Cerrahpasa Medical Faculty 1
  • Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital 1
  • Istanbul University-Cerrahpaşa, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Istanbul, Turkey 1
  • Gehad Salem Mohamed Mohamed Menshawi 1
  • Istanbul University-Cerrahpasa 1
  • Bakırköy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital 1
  • Haliç University 1
  • Istanbul Physical Medicine and Rehabilitation Trainig and Research Hospital 1
  • Istanbul, Prof. Dr. Cemil Taşçıoğlu City Hospital, Turkey 1
  • Prof. Dr. Cemil Taşçıoğlu City Hospital 1

Ankara

  • Hacettepe University 2
  • Baskent University Ankara Hospital 2
  • Hacettepe University of Medicine 1
  • Gazi University Medical Faculty 1
  • Ankara City Hospital 1
  • Ankara Etlik City Hospital 1
  • Hacettepe University, Faculty of Physical Therapy and Rehabilitation 1
  • Ankara Yıldırım Beyazıt University 1
  • Atılım University 1

Konya

  • Selcuk University Faculty of Medicine Hospital MS Life Center 3
  • Selcuk Universitesi Selcuklu Tip Fakultesi Hastanesi 1
  • Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation 1

Izmir

  • Ege University Medical Faculty 1
  • Izmir Katip Celebi Universitesi Ataturk Research and Training Hospital 1
  • Ege University Faculty of Medicine, Department of Neurology 1

Van

  • Van Yüzüncü Yıl University 1
  • Van Yüzüncü Yıl University Dursun Odabaş Medical Center 1
  • Van Regional Training and Research Hospital 1

Elâzığ

  • Fırat University 2
  • Gül DURAL 1

Kütahya

  • Kütahya Sağlık Bilimleri Üniversitesi, Sağlıklı Yaşam Fizyoterapi ve Rehabilitasyon Merkezi 1
  • Kutahya Health Sciences University Physical Medicine and Rehabilitation Department 1

Kayseri

  • Erciyes University 2

Samsun

  • Ondokuz Mayıs Universitesi 1

Kocaeli

  • Kocaeli University Medical Faculty 1

Hatay

  • Hatay Mustafa Kemal Universty 1

Mersin

  • Mersin University 1

Muğla

  • Muğla Sıtkı Koçman University 1

Niğde

  • Nigde Omer Halisdemir University 1

Köseköy

  • Kocaeli University Hospital - Department of Neurology 1

Bursa

  • Bursa Uludag University 1

Isparta

  • Süleyman Demirel Üniversitesi Araştırma ve Uygulama Hastanesi 1

Afyonkarahisar

  • Afyonkarahisar Health Sciences University 1

Gaziantep

  • SANKO University 1

Bağcılar

  • Bağcılar Training and Research Hospital 1

Erciyes

  • Erciyes University Faculty of Medicine Hospitals 1

Antalya

  • Baskent University Alanya Hospital 1
🇨🇭Switzerland54

Zurich

  • Novartis Investigative Site 1
  • Universitätsspital Zürich, Klinik für Rheumatologie, Rämistrasse 100 1
  • Bellevue Medical Group - Neurozentrum Sternen / Neurozentrum Bellevue 1
  • University of Zurich 1
  • NeuroPraxis Zürich GmbH 1
  • Bellevue Medical Group - Neurozentrum Seefeld 1
  • Klinik Lengg AG 1
  • Bellevue Medical Grop AG 1
  • University Children's Hospital Zurich 1
  • University of Zurich; Epidemiology, Biostatistics & Prevention Institute 1
  • Univeristy Hospital Zürich 1

Basel

  • University Hospital Basel, Department of Neurology 3
  • MS Centre, Neurology, University hospital Basel 1
  • Neurozentrum Basel Messeturm 1
  • Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) 1
  • Novartis Investigative Site 1
  • University Children's Hospital Basel, UKBB 1
  • Lab for Exp Otoneurology, University Hospital Basel 1
  • University Hospital Basel 1

Bern

  • Novartis Investigative Site 2
  • Inselspital-Universitaetsspital Bern 1
  • Inselspital Bern 1
  • Inselspital 1
  • University Hospital of Bern Inselspital 1
  • University Children's Hospital, Inselspital Bern 1
  • Institute of Social and Preventive Medicine, University of Bern 1
  • University Hospital Berne 1

Lausanne

  • Novartis Investigative Site 2
  • Service universitaire de neuroréhabilitation 1
  • University Children's Hospital Lausanne (CHUV) 1
  • University Hospital Lausanne 1

Lucerne

  • Luzerner Kantonsspital 2
  • Lucerne Cantonal Hospital 1
  • Kinderspital Zentralschweiz 1

Rheinfelden

  • Reha Rheinfelden, Salinenstrasse 98 1
  • Research Department, Reha Rheinfelden 1

Valens

  • Rehabilitation clinic Valens 1
  • Rehabilitation Centre Valens 1

Aarau

  • Kantonsspital Aarau 1
  • Cantonal Hospital Aarau 1

Sankt Gallen

  • Children's Hospital of Eastern Switzerland 1
  • Cantonal Hospital St. Gallen 1

Geneva

  • University Hospitals of Geneva (HUG) 1
  • University Hospital Geneva 1

Winterthur

  • Kantonsspital Winterthur 1

Bellinzona

  • Pediatric Institute of Southern Switzerland, Ospedale San Giovanni 1

Chur

  • Kantonsspital Graubünden 1

Fribourg

  • Hôpital Fribourgeois - Freiburger Spital 1

Lugano

  • Regional Hospital Lugano 1
🇺🇦Ukraine43

Lviv

  • Limited Liability Company Medical Center Neuroclinic 2
  • Limited Liability Company "Neurofocus" 2
  • Lvivska oblasna tsentralna likarnia 1
  • TG Therapeutics Investigational Trial Site 1
  • UH of State NPC Danulo Halytsky NMU in Lviv CID, Clinic of Neurology and Neurosurgery 1

Ivano-Frankivsk

  • CNE City Clinical Hospital #1 of Ivano-Frankivsk council 2
  • Regional Clinical Hospital 1
  • TG Therapeutics Investigational Trial Site 1

Chernivtsi

  • Regional Municipal Non-commercial Enterprise Chernivtsi Emergency Medical Hospital 2
  • Bukovinsky SMU RMI Chernivtsi RCH 1

Vinnytsia

  • Medical Clinical Investigational Center of Medical Center LLC Health Clinic 2
  • TG Therapeutics Investigational Trial Site 1

Kyiv

  • Medical Center Dopomoga Plus 1
  • Medical Center of Private Execution First Private Clinic 1
  • TG Therapeutics Investigational Trial Site 1

Chernihiv

  • Mun.Med.Proph.Inst.?Chernihiv Reg.Hosp.? 1
  • TG Therapeutics Investigational Trial Site 1

Zaporizhzhya

  • LCC "Medical center "Unimed" 1
  • Municipal Non-profit Enterprise Zaporizhzhya Regional Hospital Zaporizhzhya Regional Council 1

Cherkasy

  • 5th Cherkasy City Center of Primary Health Care 1

Dnipro

  • SI USSRI of Medical and Social Problems of Disabilities of MOHU 1

Kharkiv

  • St.In.Inst. of Neurol.Psych.and Narcol.of the AMSU 1

Lutsk

  • Volyn Regional Clinical Hospital 1

Vinnytsi

  • Medical Clinical Research Center of Medical Center LLC Health Clinic 1

Odesa

  • TG Therapeutics Investigational Trial Site 1

Poltava

  • TG Therapeutics Investigational Trial Site 1

Ternopil

  • TG Therapeutics Investigational Trial Site 1

Uzhhorod

  • TG Therapeutics Investigational Trial Site 1
🇨🇿Czechia35

Prague

  • Novartis Investigative Site 2
  • Thomayer University Hospital - Fakultni Thomayerova nemocnice 1
  • National Institute of Mental Health 1
  • Vseobecna fakultni nemocnice v Praze 1
  • Fakultni Thomayerova nemocnice 1
  • Local Institution - 0011 1
  • University Hospital Kralovske Vinohrady, Department od Rehabilitation Medicine 1
  • Assossiation for Body in Balance 1
  • General University Hospital Prague 1

Hradec Králové

  • Fakultni Nemocnice Hradec Kralove 2
  • Novartis Investigative Site 2
  • NEUROHK s.r.o. 1
  • Fakultni nemocnice Hradec Kralove 1

Teplice

  • Nemocnice Teplice 2
  • Novartis Investigative Site 1

Jihlava

  • Novartis Investigative Site 2
  • Regional Hospital Jihlava 1

Brno

  • Novartis Investigative Site 2
  • Fakultni Nemocnice u sv. Anny v Brne 1

Pardubice

  • Novartis Investigative Site 1
  • Nemocnice Pardubického kraje 1
  • Nemocnice Pardubickeho kraje, a.s., Pardubicka nemocnice 1

Choceň

  • NEUROHK, s.r.o. 2

Zlín

  • Local Institution - 0077 1

Olomouc

  • University hospital Olomouc 1

Ostrava

  • University Hospital Ostrava 1
🇵🇹Portugal34

Lisbon

  • Novartis Investigative Site 3
  • Centro Hospitalar de Lisboa Central 1
  • ULS São José - Hospital de Sto António dos Capuchos;CRI Esclerose Múltipla 1
  • Hospital de Egas Moniz 1
  • Champalimaud Foundation 1

Braga

  • Novartis Investigative Site 2
  • 2Ca Braga 1
  • Hospital de Braga 1
  • Centro Clnico Acadmico - Braga, Associao (2CA-Braga) 1
  • Clinical Academic Center - Braga (2CA-Braga) 1

Coimbra

  • Novartis Investigative Site 1
  • Unidade Local de Saúde de Coimbra, E.P.E. 1
  • ULS de Coimbra, EPE - Hospitais da Universidade de Coimbra 1
  • Unidade Local de Saude de Coimbra E P E 1
  • Local Health Unit of Coimbra 1
  • Unidade Local de Saude de Coimbra 1

Porto

  • Novartis Investigative Site 2
  • Local Institution - 0102 1
  • Centro Hospitalar Universitário de São João 1

Santa Maria da Feira

  • Centro Hospitalar Entre o Douro e Vouga E.P.E. - Hospital de São Sebastião 1

Amadora

  • Novartis Investigative Site 1

Guimarães

  • Novartis Investigative Site 1

Leiria

  • Novartis Investigative Site 1

Matosinhos Municipality

  • Novartis Investigative Site 1

Ponte de Lima

  • Novartis Investigative Site 1

Setúbal

  • Novartis Investigative Site 1
🇬🇷Greece31

Athens

  • Novartis Investigative Site 2
  • Errikos Dunant Hospital 1
  • Prodromos Stem Cell Institute 1
  • Aretaieio Hospital, University of Athens 1
  • Aretaieio Hospital 1

Chaïdári

  • Novartis Investigative Site 3

Ioannina

  • Novartis Investigative Site 2
  • Division of Physical Medicine and Rehabilitation/Department of Surgery, University of Ioannina Medical School 1

Larissa

  • Novartis Investigative Site 3

Thessaloniki

  • Novartis Investigative Site 3

Pátrai

  • Department of Physiotherapy of the School of Health Rehabilitation Sciences, University of Patras 1
  • Novartis Investigative Site 1

Cholargós

  • Metropolitan General Hospital 1

Alexandroupoli

  • Novartis Investigative Site 1

Crete Heraklion

  • Novartis Investigative Site 1
🇧🇪Belgium26

Brussels

  • Investigational Site Number : 0560008 1
  • Novartis Investigative Site 1
  • Universitair Ziekenhuis Brussel 1
  • University hospital of Brussels 1
  • CHU Brugmann 1
  • Université Catholique de Louvain 1

Leuven

  • UZ Leuven 2
  • Novartis Investigative Site 1
  • KU Leuven 1

Overpelt

  • MS-Netwerk Limburg - Revalidatie 1
  • Investigational Site Number : 0560005 1
  • Novartis Investigative Site 1

Diepenbeek

  • Hasselt University 1
  • REVAL Rehabilitation Research Center, University of Hasselt 1
  • REVAL Rehabilitation Research Center 1

Bruges

  • Investigational Site Number : 0560001 1
  • Novartis Investigative Site 1

Melsbroek

  • National MS Center Melsbroek 2

Ghent

  • Investigational Site Number : 0560006 1

Kortrijk

  • Investigational Site Number : 0560007 1

Roeselare

  • Novartis Investigative Site 1

Bonheiden

  • Novartis Investigative Site 1

Edegem

  • Universitair Ziekenhuis Antwerpen (UZA) 1

Steenokkerzeel

  • Nationaal MS Center Melsbroek 1
🇳🇱Netherlands25

Amsterdam

  • Amsterdam UMC 2
  • Novartis Investigative Site 1
  • Amsterdam UMC, location VUmc 1
  • Amsterdam University Medical Centers, location VUmc 1

Arnhem

  • Novartis Investigative Site 1
  • Rijnstate 1
  • Rijnstate Arnhem 1

's-Hertogenbosch

  • Novartis Investigative Site 1
  • Jeroen Bosch Ziekenhuis 1

Leiden

  • Novartis Investigative Site 1
  • Health, Medical and Neuropsychology, Institute of Psychology, Faculty of Behvavioural and Social Siences, Leiden University 1

Groningen

  • University Medical Center Groningen 1
  • University Medical Center Groningen (UMCG) 1

Utrecht

  • Universitair Medisch Centrum Utrecht 2

Geleen

  • Zuyderland Medisch Centrum 1
  • Zuyderland Medical Center 1

Rotterdam

  • Erasmus MC 1
  • Erasmus Medical Center 1

Sittard

  • Zuyderland Medisch Centrum - Sittard-Geleen 1

Sittard-Geleen

  • Novartis Investigative Site 1

Dordrecht

  • Albert Schweitzer ziekenhuis 1

Maastricht

  • Maastricht University Medical Center 1

Nieuwegein

  • St. Antonius Hospital 1
🇧🇬Bulgaria23

Sofia

  • Diagnostic and Consultative Center Convex 2
  • Medical Center Hera EOOD 2
  • DCC Neoclinic - Sofia 1
  • Novartis Investigative Site 1
  • MHATNP Sveti Naum EAD 1

Pleven

  • Avis Medica Hospital Pleven 2
  • UMHAT Dr Georgi Stranski 1
  • Novartis Investigative Site 1
  • MHAT Avis Medica OOD Department of Neurology 1
  • UMHAT 'Dr. Georgi Stranski', EAD 1

Plovdiv

  • Medical Center Nevrocentrum 2

Veliko Tarnovo

  • Medical Center Medica Plus OOD 2
🇧🇷Brazil23

São Paulo

  • Novartis Investigative Site 2
  • Centro de Pesquisas Clinicas - CPCLIN 2

Joinville

  • Novartis Investigative Site 2
  • Clínica Neurológica- Site Number : 0760007 1

Porto Alegre

  • Novartis Investigative Site 2
  • Nucleo de Pesquisa Clinica do Rio Grande do Sul NPCR 1

Brasília

  • L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760003 1
  • L2IP ?Instituto de Pesquisas Clínicas Ltda. 1

Curitiba

  • Instituto de Neurologia de Curitiba - Ecoville- Site Number : 0760001 1
  • Instituto de Neurologia de Curitiba - Hospital Ecoville 1

Fortaleza

  • Novartis Investigative Site 2

Rio de Janeiro

  • Novartis Investigative Site 1

Santo André

  • Novartis Investigative Site 1
🇦🇷Argentina21

Rosario

  • Novartis Investigative Site 2
  • INECO Neurociencias Orono 1

Buenos Aires

  • Novartis Investigative Site 2

Caba

  • Novartis Investigative Site 2

CABA

  • Novartis Investigative Site 1

Capital Federal

  • Novartis Investigative Site 1

Bombal

  • Novartis Investigative Site 1

San Juan

  • Novartis Investigative Site 1

Santiago del Estero

  • Novartis Investigative Site 1

San Miguel de

  • Novartis Investigative Site 1

San Miguel de Tucumán

  • Sanatorio del Sur S.A. 1
🇩🇰Denmark21

Copenhagen

  • Bispebjerg Hospital 1
  • Section of Movement and Neuroscience, Department of Nutrition, Exercise, and Sports, University of Copenhagen 1
  • Department of Nutrition, Exercise and Sports, University of Copenhagen 1
  • Respiratory Center East 1

Glostrup Municipality

  • Novartis Investigative Site 2
  • Glostrup Hospital 1

Ry

  • The Danish MS Hospitals 2
  • The Danish MS Hospitals, Ry 1

Aarhus N

  • Novartis Investigative Site 2

Haslev

  • The Danish MS Hospitals 1
  • The Danish MS Hospitals, Haslev 1

Aarhus

  • Aarhus University 1
  • Department of Public Health 1

Esbjerg

  • Novartis Investigative Site 1

Odense C

  • Novartis Investigative Site 1

Roskilde

  • Zealand University Hospital Roskilde 1

Hvidovre

  • Danish Research Centre for Magnetic Resonance 1

Odense

  • Odense University Hospital 1
🇸🇪Sweden19

Stockholm

  • Novartis Investigative Site 1
  • Karolinska Universitetssjukhuset 1
  • Karolinska Institutet 1
  • Academic specialist center, Center for Neurology 1

Gävle

  • Gävle hospital 2
  • Gävle sjukhus, Neurologmottagningen 1

Huddinge

  • Research Site 1
  • Karolinska University Hospital, Karolinska Institutet-ALS Center-Department of Clinical Neuroscience 1

Umeå

  • Noorlands University Hospital-Department of Neurology 1
  • Umeå University Hospital 1

Gothenburg

  • Novartis Investigative Site 1

Falun

  • Falu Lasarett, Neurologen 1

Karlstad

  • Centralsjukhuset Karlstad, Neurologi och Rehabiliteringskliniken 1

Uppsala

  • Uppsala University Hospital 1

Ängelholm

  • Memory Clinic, Hospital of Ängelholm 1

Malmö

  • Memory Clinic, Skåne University Hospital 1

Solna

  • Aleris Rehab Station 1

Bergshamra

  • Ottobock Care Sverige 1
🇭🇺Hungary18

Budapest

  • National Institute of Clinical Neurosciences 1
  • Novartis Investigative Site 1
  • Clinexpert Kft. 1
  • S-Medicon Egeszsegugyi Szolgaltato Kft. 1
  • Semmelweis Egyetem 1
  • Bajcsy-Zsilinszky Korhaz es Rendelointezet 1
  • Budapesti Uzsoki Utcai Kórház 1

Tatabánya

  • Komarom-Esztergom Varmegyei Szent Borbala Korhaz 1
  • Novartis Investigative Site 1

Pécs

  • Novartis Investigative Site 1
  • Pecsi Tudomanyegyetem Klinikai Kozpont 1

Kaposvár

  • Somogy Varmegyei Kaposi Mor Oktato Korhaz 1
  • Somogy County Kaposi Mór Teaching Hospital 1

Esztergom

  • Valeomed Kft. 1

Kistarcsa

  • Novartis Investigative Site 1

Debrecen

  • Debreceni Egyetem Klinikai Kozpont Kenezy Gyula Campus 1
🇷🇺Russia18

Saint Petersburg

  • SBIH City Clinical Hospital #31 1
  • LLC Osnova 1
  • N.P. Bechtereva Institute of the Human Brain 1
  • City Hospital #40 of Kurortniy Administrative District 1
  • First Pavlov State Medical University of St. Petersburg 1

Krasnoyarsk

  • Krasnoyarsk State Medical Academy 1
  • FSBHI Siberian Clinical Center of the Federal Medical and Biological Agency 1

Moscow

  • Research Center of Neurology of RAMS 1
  • City Clinical Hospital #24 1

Nizhny Novgorod

  • LLC "Medis" 1

Moskva

  • Federal center of brain research and neurotechnologies 1

Yekaterinburg

  • SHI Sverdlovsk Regional Clinical Hospital #1 1

Kazan'

  • Vertebronevrologiya LLC 1

Ulyanovsk

  • Ulyanovsk Regional Clinical Hospital 1

Kirov

  • Center of Cardiology and Neurology 1

Krasnodar

  • Regional clinical hospital named after prof. S.V. Ochapovsky 1

Novosibirsk

  • FSBIH Siberian Regional Medical Centre of FMBA of Russia 1

Perm

  • Perm SMA n.a. academ. E.A. Vagner 1
🇬🇪Georgia17

Tbilisi

  • MD Georgia Staff Physician MediClub Georgia 2
  • LTD Pineo Medical Ecosystem 2
  • NNLE Jo Ann University Hospital 2
  • Caucasus Medical Center Ltd 2
  • Raymann, LLC 2
  • JSC Curatio 1
  • TG Therapeutics Investigational Trial Site 1

Rustavi

  • TG Therapeutics Investigational Trial Site 1
🇮🇱Israel12

Jerusalem

  • Novartis Investigative Site 1
  • Hadassah University Hospital 1
  • Hadassah MO 1

Tel Aviv

  • Novartis Investigative Site 1
  • Tel Aviv University 1
  • Tel Aviv Sourasky medical center 1

Ashkelon

  • Novartis Investigative Site 1

Hadera

  • Novartis Investigative Site 1

Haifa

  • Novartis Investigative Site 1

Ramat Gan

  • Novartis Investigative Site 1

Rehovot

  • Novartis Investigative Site 1

Tsrifin

  • Novartis Investigative Site 1
🇲🇽Mexico12

Mexico City

  • Novartis Investigative Site 2
  • Local Institution - 0078 1
  • Clinstile S.A de C.V. 1
  • Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social 1
  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán 1
  • Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de México 1

Chihuahua City

  • Novartis Investigative Site 1

Benito Juárez

  • Novartis Investigative Site 1

San Luis Potosí City

  • Novartis Investigative Site 1

Culiacán

  • Neurociencias Estudios Clinicos S.C. 1
🇷🇴Romania11

Bucharest

  • Novartis Investigative Site 1
  • Spitalul Clinic de Copii Doctor Victor Gomoiu 1
  • Prof. Dr. Alexandru Obregia Psychiatry Hospital 1
  • Fundeni Clinical Institute 1

Constanța

  • Spital Clinic CF Constanta 2
  • Novartis Investigative Site 1

Brasov

  • Clinical Hospital of Psychiatry and Neurology 1

Târgu Mureş

  • Spitalul Clinic Judetean Mures 1

Radauti

  • Spitalul Municipal Sf. Doctori Cosma si Damian Radauti 1

Campulung Muscel

  • Novartis Investigative Site 1
🇯🇵Japan11

Sapporo

  • Investigational Site Number : 3920017 1
  • Hokkaido University Hospital 1

Kyoto

  • Investigational Site Number : 3920001 1
  • Kyoto University Hospital 1

Kōriyama

  • Investigational Site Number : 3920003 1

Yahaba

  • Investigational Site Number : 3920008 1

Higashi-Matsuyama

  • Investigational Site Number : 3920015 1

Kodaira

  • Investigational Site Number : 3920016 1

Tokyo

  • Investigational Site Number : 3920012 1

Tokushima

  • Tokushima University Hospital 1

Ōta-ku

  • Toho University Omori Medical Center 1
🇷🇸Serbia10

Kragujevac

  • University Clinical Centre of Kragujevac 2
  • Clinical Centre Kragujevac, Neurology clinic 1
  • TG Therapeutics Investigational Trial Site 1

Belgrade

  • University Clinical Centre of Serbia 2
  • TG Therapeutics Investigational Trial Site 1
  • University Clinical Center of Serbia 1

Niš

  • Clinic of Neurology - Clinical Center Nis 2
🇸🇰Slovakia10

Bratislava

  • Novartis Investigative Site 2
  • TG Therapeutics Investigational Trial Site 1
  • 2nd Department of Neurology, Faculty of Medicine, Comenius University Bratislava and University Hospital Bratislava 1

Trnava

  • Novartis Investigative Site 2

Banská Bystrica

  • Mudr. Beata Dupejova, neurologická ambulancia S.R.O. 1

Komárno

  • Novartis Investigative Site 1

Nitra

  • Novartis Investigative Site 1
🇮🇳India8

Gurugram

  • Novartis Investigative Site 1

Mangalore

  • Novartis Investigative Site 1

Kochi

  • Novartis Investigative Site 1

New Delhi

  • Novartis Investigative Site 1

Chandigarh

  • Novartis Investigative Site 1

Vellore

  • Novartis Investigative Site 1

Hyderabad

  • Novartis Investigative Site 1
🇪🇬Egypt8

Cairo

  • faculty of physical therapy, Cairo university 1
  • El Mounira Multiple Sclerosis Unit 1
  • Naser Institute MS Unit 1

Giza

  • Kasr Alainy Multiple Sclerosis Unit (KAMSU), Cairo University hospitals. 1
  • Faculty of Physical Therapy, Cairo University 1

Banhā

  • Banha University Hospitals 1

Asyut

  • Assiut university neurology hospital 1

Alexandria

  • multiple sclerosis specialized clinic in the Neurology department, Faculty of Medicine, Alexandria University. 1
🇵🇷Puerto Rico6

Guaynabo

  • Caribbean Center for Clinical Research 3
  • TG Therapeutics Investigational Trial Site 1

Caguas

  • Local Institution - 0134 1
  • Puerto Rico Multiple Sclerosis Center 1
🇦🇹Austria6

Vienna

  • Novartis Investigative Site 1
  • Department of Clinical Pharmacology, Medical University of Vienna 1

Innsbruck

  • Novartis Investigative Site 1

Linz

  • Novartis Investigative Site 1
🇭🇷Croatia5

Zagreb

  • Klinicki Bolnicki Centar Zagreb-Rebro 2
  • Novartis Investigative Site 1

Varaždin

  • Novartis Investigative Site 1

Split

  • University of Split School of Medicine 1
🇮🇪Ireland5

Dublin

  • Novartis Investigative Site 1
  • MS Ireland 1
  • St. James's Hospital 1
  • Trinity College Dublin 1
  • St Vincent's University Hospital 1
🇧🇦Bosnia and Herzegovina5

Bihać

  • TG Therapeutics Investigational Trial Site 1

Mostar

  • TG Therapeutics Investigational Trial Site 1

Sarajevo

  • TG Therapeutics Investigational Trial Site 1

Tuzla

  • TG Therapeutics Investigational Trial Site 1

Zenica

  • TG Therapeutics Investigational Trial Site 1
🇦🇪United Arab Emirates5

Sharjah city

  • University of Sharjah 1
  • Alham Al Sharman 1

Dubai

  • The Saudi-German Hospital 1

Abu Dhabi

  • Yas Clinic 1

Marina

  • Harley Street Medical Centre 1
🇪🇪Estonia4

Tallinn

  • Astra Clinic (Clinic4U) 1
  • Astra clinic (Clinic4U) 1
  • Novartis Investigative Site 1

Tartu

  • Novartis Investigative Site 1
🇨🇴Colombia4

Barranquilla

  • Novartis Investigative Site 1

Bogotá

  • Novartis Investigative Site 1

Medellín

  • Novartis Investigative Site 1
🇹🇼Taiwan4

Taipei

  • National Taiwan University Hospital 1
  • Taipei Veterans General Hospital 1

Kaohsiung City

  • Kaohsiung Chang Gung Memorial Hospital 1

Taichung

  • China Medical University Hospital 1
🇵🇪Peru4

Lima

  • Hospital Nacional Dos de Mayo 1
  • Instituto Nacional de Ciencias Neurológicas - Hospital Mogrovejo 1

Bellavista

  • Hospital IV Alberto Sabogal Sologuren 1

La Victoria, Lima

  • Hospital Nacional Guillermo Almenara Irigoyen 1
🇳🇴Norway4

Bergen

  • Haukeland University Hospital 1
  • Haukeland University Hospital, Deparment of medical biochemistry and pharmacology 1

Oslo

  • Oslo University Hospital 2
🇿🇦South Africa3

Cape Town

  • Novartis Investigative Site 2

Pretoria

  • Novartis Investigative Site 1
🇱🇹Lithuania2

Kaunas

  • Hospital of Lithuanian University of Health Sciences 1
  • Novartis Investigative Site 1
🇸🇮Slovenia2

Ljubljana

  • Novartis Investigative Site 1
  • University Medical Centre 1
🇲🇰North Macedonia2

Shtip

  • TG Therapeutics Investigational Trial Site 1

Skopje

  • TG Therapeutics Investigational Trial Site 1
🇳🇿New Zealand2

Christchurch Central City

  • Optimal Clinical Trials - Christchurch 1

Auckland

  • Optimal Clinical Trials - Central 1
🇰🇷South Korea2

Seoul

  • Hanyang University Seoul Hospital 1
  • Seoul National University Hospital 1
🇱🇺Luxembourg2

Luxembourg

  • Rehazenter, Centre National de Rééducation fonctionnelle et de Réadaptation 1
  • Centre Hospitalier de Luxembourg 1
🇩🇿Algeria2

Oran

  • Aboubakr abdelmadjid 1
  • Zitouni-Nourine Saida Hanane 1
🇱🇻Latvia1

Riga

  • Novartis Investigative Site 1
🇵🇰Pakistan1

Lahore

  • Jinnah Hospital 1
🇸🇦Saudi Arabia1

Khobar

  • King Fahd Hospital of the University 1
🇭🇰Hong Kong1

Hong Kong

  • The Chinese University of Hong Kong 1
🇲🇶Martinique1

Fort-de-France

  • Hopital P. Zobda-Quitman 1

Source: ClinicalTrials.gov study locations, fetched 2026-11-10. Counts are trials at that site.